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Abstract 
 
 
 
The sialic acids are a family of acid sugars that are widely distributed in mammal cells and are found 
typically linked to the distal end of glycan chains in mammalian glycoproteins, including the mucin 
proteins found on mucosal surfaces. The most common sialic acid, N-acetyl neuraminic acid or 
Neu5Ac is often found with additional O-linked acetyl group s when located on gut epithelial cell 
surfaces. In Escherichia coli the enzyme NanS functions as a sialate O-acetylesterase, to remove the 
additional acetyl groups and allow use of these O-acetylated sialic acids for nutrition. Although NanS 
has a cytoplasmic location in E. coli, human faecal extracts have been found to contain extracellular 
sialate-O-acetylesterase activity, which is thought to correlate to the presence of bacteria from the 
Bacteroides genes. We have identified in silico the genes encoding potential sialate O- 
acetylesterases across a range of Bacteroides species and for Bacteroides thetaiotamicron, the most 
abundant commensal species of Bacteroides in the gut, there are 10 potential candidates. 
Preliminary expression experiments indicated that these proteins are highly insoluble after 
expression in E. coli conventional vectors and increased solubility was dependent on the expression 
of the target protein with a range of different protein fusion partners. Basic acetylesterase enzyme 
assays, using p-nitrophenylacetate as a standard substrate, demonstrated that a number of these 
proteins have detectable acetyl esterase activity. A subset of these proteins are predicted to be 
secreted and hence could be responsible for the previously reported sialate O-acetylesterase activity 
present in the gut. The identification of this activity is potentially significant as alteration in levels of 
O-acetylation of gut proteins are known to be connected to progression of gastrointestinal cancer. 
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Introduction 
 
Sialic acids (also referred to as neuraminic acids) are nine carbon keto sugars that are widely 
distributed among mammals and metazoans. They were first identified by two German Biochemists. In 
1936 Blix isolated what he termed ‘carbohydrate I’ in a crystallised form from bovine submaxillary 
mucin (Blix et al, 1936). In 1941 Klenk observed the presence of what he called neuroamine isolated 
from glangliosides in brain matter (Klenk et al, 1941). Following these initial discoveries, many other 
forms of the substances were identified, but it wasn’t until the 1950’s that it became evident that 
these were variant on the compounds described by Blix and Klenk and that the term neuraminic acid 
was established as the name for the basic, unsubstituted structure common to all the described 
substances (Blix et al, 1936; Klenk et al, 1941; Godoy et al, 1993; Faillard et al, 1989; Vimr et al, 
2004). Although sialic acid encompasses an entire group of nine carbon sugars, the term itself is used 
to refer to the most common and widely studied of the sugars, N-acetylneuraminic acid (Neu5Ac) 
(Severi et al, 2007). The name sialic acid is consistent with the discovery of the carbohydrate in bovine 
submaxillary mucin and stems from the Greek word sialon meaning saliva (Blix et al, 1936; Vimr et al, 
2004). Since these initial discoveries over 50 naturally occurring sialic acids have been identified 
(Angata and Varki, 2002). 
 
Sialic acids were initially thought to be exclusive to higher metazoans but have since been shown to 
be present in certain prokaryotes (Vimr et al, 2004). Given that sialic acids are typically known to be 
linked to the distal end of glycan chains, they are in a prime position to be utilized by 
microorganisms. It comes as no surprise then, that many commensal and pathogenic bacteria use 
environmental and host sialic acids as a source carbon, nitrogen and energy and for assembly into 
cell wall components (Plumbridge and vimr, 1999; Vimr et al, 2004; Severi et al, 2005). 
 
Sialic acid structure 
 
 
Sialic acids originate from a 2-keto-3-deoxy-5-acetamido-D-glycero-D-galacto-nonulosonic acid 
parent compound. The basic sialic acid backbone is most commonly found in nature as a 
neuroaminic acid with either an N- acetyl or an N-glycolyl group at the C-5 position on the carbon 
ring (Varki et al, 2007). Although Neu5Gc is the second most abundant form of sialic acid seen in 
many vertebrates (mammals, birds, amphibians, reptiles and fish) it is not present in bacteria or 
archaea (Vimr et al, 2004). It is interesting to note that although this form of sialic acid is present in 
humans, the mammalian structural gene required for the addition of the N-glycolyl group is inactive. It 
is thought that the mutation resulting in a deletion of one of the exons occurred after the
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divergence of humans from the great apes (Vimr et al, 2004; Angata and Varki, 2002). To date three 
types of sialic acid have been identified to be produced in bacteria: Neu5Ac, pseudaminic acid 
(Pse5,7Ac) and legionaminic acid (Leg5,7Ac). All three are derivatives of 4 isomeric 5,7-diamino- 
3,5,7,9-tetradeoxynon-2-ulosonic acids (Knirel et al, 2003). Both Pse and Leg have structural and 
biosynthetic similarities to sialic acid (Fig 1. Lewis et al, 2009). Each of these variations is dependent 
on the condensation of a 6 carbon sugar intermediate with the 3 carbon phosphoenolpyruvate to 
generate the final 9 carbon backbone (as described in more detail in below). Pse and Leg 
modifications both play a role in flagellar assembly and therefore a role in bacterial motility, although 
in Leg this is less well defined (McNally et al, 2006; McNally et al, 2007; Schirm et al, 2003; Logan et 
al, 2009; Twine et al, 2008). Pse and Leg have both been identified in LPS O antigens of 
various Gram negative bacterium indicating an involvement in biofilm formation, resistance to phage 
 
predation and animal association (Almagro and Boyd, 2010; Severi et al, 2007; Vimr et al, 2007; 
 
Lewis et al, 2009). Despite being closely related to Neu5Ac the host-pathogen interactions of Pse and 
 
Leg are poorly defined (Lewis et al, 2009). 
 
 
Over the years many sialic acid derivatives have been identified and are all biosynthetic derivatives 
 
of either Neu5Ac or KDN (3-deoxy-D-glycero-D-galacto-2-nonulosonic acid) (Angata and Varki, 2002). 
Modifications of sialic acid include the addition of up to three acetyl groups at the C4 position and at 
hydroxyl positions C-7 to C-9 (Vimr et al, 2004). Sialic acids with lactyl, sulfhydryl, phosphate or methyl 
groups have also been identified but these modifications are less common than those observed 
through the addition of acetyl groups (Fig. 1. Schauer, 2004). 
 
Although usually found as part of complex structures such as glycolipids and glycoproteins, they can 
also be bound to structures which are composed entirely of sugars (oligosaccharides and some 
polysaccharides) (Vimr et al, 2004). Positioning of sialic acids at distal ends of glycan chains means 
they are in the perfect place for interactions with other cells and environmental agents (Angata and 
Varki, 2002). In eukaryotic cells sialic acids are mostly expressed on glycan chains of glycoproteins and 
glycolipids. In most cases they are linked via α2-3 linkages to Gal, α2-6 linkages to Gal, GalNAc or via a 
α2-9 linkage to other sialic acids (Tsuji et al, 1996; Angata and Varki, 2002). As well as these commonly 
seen linkages, there are a few rarer forms of linkages seen in eukaryotes. These include 
α2-3 linkages to GalNAc, α2-6 linkages to GlcNAc and Glc, α2-4 linkages to Gal and GlcNAc, α2-9 
 
linkages to other sialic acids and Neu5Gc oligomer linked via hydroxyl group of N-glycolyl (Iwasaki et 
al, 1984; Kubo et al, 1990; Angata and Varki, 2002). 
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Figure 1 - Naturally occurring sialic acids. A. The various residues indicated in the image can be 
combined on the basic Neu5Ac backbone depending on the species or tissue (Schauer, 2004). B. 
Variations to the basic 9 carbon sugar backbone seen in legionaminic acid and pseudaminic acid (Lewis 
et al, 2009). 
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Sialic Acid and Bacteria 
 
 
As mentioned previously it was initially thought that Neu5Ac was absent in prokaryotes, however over 
the years an increasing number of pathogenic bacteria have been found to encode sialic acid 
metabolism genes. Sialic acid metabolism in bacteria falls into two broad categories: biosynthesis with 
sialylation and scavenging with catabolism. Bacteria that are able to synthesize sialic acid are 
pathogenic in general and are able to utilize the sialic acid to coat several structures on their surface. 
The ability to decorate their surfaces gives these bacteria a competitive advantage in that they are 
able to mask themselves from the immune system and are able to alter the host cell specificity (Severi 
et al¸2005; Steenbergen et al, 2005; Brigham et al, 2009; Sharma et al, 2011; Almagro- moreno and 
Boyd, 2010; Takoa et al, 2010; Stafford et al, 2012; Spinola et al, 2012). The terminal position of host 
sialic acid has also made them the most commonly targeted carbohydrate receptor for pathogen 
adherence with examples of sialic acid binding agglutinins, adhesions and lectins in mammalian 
pathogens (Angeta et al, 2002). 
 
The use of sialic acid is best characterized in E. coli, Haemophilus influenzae, Pasteurella multocida, 
Neisseria spp, Campylobacter jejuni and Streptococcus agalactiae. Each of these use the sialic acid in 
different ways to colonize, persist and cause disease to a mammalian host (Severi et al, 2007). 
Bacteria use sialic acid in at least two different ways; they are able to either use it as a source of 
nutrients or as part of the host immune evasion mechanism (Severi et al, 2007). 
 
Many pathogenic bacteria have evolved to include the sialic acid in a large range of glycoconjugates 
decorating the cell surface including capsular polysaccharides or CPS (K-antigens), lipopolysacharides 
or LPS (O-antigens), S-layer glycoproteins and peptidoglycans (cell wall component). When sialic 
acids are present in bacteria they are mainly found in the CPS or LPS and confers an important 
 
phenotype involved in innate immune resistance and interaction with host cells (Severi et al, 2007). 
 
 
Following sialic acid uptake bacterial cells are able to incorporate the sialic acid into cell surface 
macromolecules leading to the ability to modulate the interactions with the host (Fig. 2. Severi et al, 
2007). The first step in this process is the activation of the sialic acid into CMP-Neu5Ac, which is then 
added to acceptors by sialyltranferases which are linkage specific (Severi et al, 2007). In E. coli it is 
NeuA which activates the Neu5Ac prior to addition of the sialic acid into K1 and K92 capsules. NeuS 
is the polysialyltranferase which adds the activated Neu5Ac to the oligosialic acid receptor leading to 
the production of the PSA capsule (Vimr et al, 2004; Severi et al, 2007). Through the action of NeuO 
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and NeuD, the sialic acid in the synthesised PSA is modified by O-acetylation. This process causes a 
large variation in the surface of the PSA capsule (Claus et al, 2004; Steenbergen et al, 2006; Deszo et 
al, 2005; Vimr et al, 2004). LPS sialylation is processed in a similar manner but is reliant on the linkage 
specific sialyltransferase Lst (Severi et al, 2007). It is interesting to note that Neisseria gonorrhoea 
relies on a scavenger (outer membrane associated) sialyltransferase to get the CMP-Neu5Ac directly 
from the secretion of the host (Shell et al, 2002). In addition to this H. influenzae actually has multiple 
charachterized sialyltransferase (4 in any given strain), the main one of which (Lic3A) has been shown 
to be essential for bacterial survival in the middle ear in the animal model for otitis media (Bochet et 
al, 2003; Severi et al, 2007). 
 
Although the process of incorporation is relatively well characterized, it is still unclear how bacteria 
maintain a balance between the catabolism of sialic acid and its incorporation into surface structures 
(Severi et al, 2007). In E. coli K1 there is the possibility of competition between sialic acid catabolism 
and polysialic acid (PSA) synthesis. However, it is predicted a tight gene regulation exists as neu 
genes (involved in sialic acid incorporation into PSA) are continuously expressed whereas genes 
involved in sialic acid catabolism (nan genes) are expressed only during exogenous sialic acid 
presence (Vimr et al¸2004; Severi et al, 2007). Evidence does suggest that in H. influenzae 
catabolism of sialic acid is in direct competition with the LPS sialylation pathway as indicated by 
hypersialylation in nanA (gene essential for sialic acid catabolism) mutant (Vimr et al, 2000; Severi et 
al, 2007). 
 
The addition of sialic acid into both the LPS and CPS allows bacterial cell immune evasion. A good 
example is the E. coli K1 PSA capsule which is poorly immunogenic due to its structural similarity of 
the PSA chains in the mammalian neuronal cell adhesion molecule NCAM (Vimr and Lichtensteiger, 
2002). Although the K1 capsule does not confer serium resistance it is able to inhibit opsonisation 
 
and phagocytosis in vivo (Vimr and Lichtensteiger, 2002). S. agalactiae CPS has similar properties and 
is able to inhibit phagocytosis by impairing the C3 deposition onto the cell surface and so leading to 
the prevention of activation of the complement alternative pathway (Marques et al, 1992; Severi et al, 
2007). 
 
In a similar way, LPS sialylation also inhibits the complement alternative pathway in both H. 
influenzae and N. gonorrhoeae. The gonococcal sialyated LPS causes an increase in the binding of 
factor H (fH) to the bacterial cell surface. The fH is an anti-activator of complement alternative 
pathway hence allowing the bacterial cell to evade innate immune system of the host cell in a way 
that mimics the host cells own defences (Ram et al, 1998). In contrast, H. influenzae inhibits the 
deposition of C3 in an fH independent manner and it has been postulated that this is due to the C3 
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target being LPS through which sialylation causes the masking of the binding site (Figueira et al, 
 
2007). There is also evidence that the sialylated bacterial surfaces of C. jejjuni, Neisseria meningitidis 
and S. agalactiae allows the bacterial cells to interact directly with sialic acid specific lectins of the 
siglec family found on the surface of immune cells. This direct interaction allows the bacterial cells to 
modulate the immune responses of the host (Avril et al, 2006; Carlin et al, 2007; Jones et al, 2003). 
 
Given the high predominance of sialic acid in complex animals, microorganisms that can degrade 
sialic acid are often close commensals or pathogens of their hosts. Genes required for sialic acid 
catabolism are mostly confined to the pathogens or commensals that colonise sialic acid rich 
environments such as the lungs and gut (Almagro-Mareono and Boyd, 2009). Although more recently 
a soil bacterium has also been shown to grow on Neu5Ac (Grutser et al, 2012). The first indication of 
exogenous sialic acid metabolism (as a potential carbon source) was seen in 1974 through its uptake 
and degradation by Clostridium perfingenus (Ness et al, 1976). It wasn’t until the 
1980’s that Vimr and Troy characterized the sialic acid degradation pathway in E. coli. While working 
 
on polysialic acid (PSA) synthesis in an E. coli K-12 strain expressing the neu genes from an E. coli K1 
strain, they observed that only 10% of the radiolabled sialic acid that was added to the growth 
medium was actually incorporated into the PSA despite the evidence of quantitative uptake. Using 
mutational analysis, under the presumption that the bacteria expressed an effective transporter and 
the appropriate degradation system, they identified a sialic acid transporter and aldolase and named 
the genes nanT and nanA respectively (Vimr and Troy, 1985). 
 
Genetic analysis alongside the completion of the K-12 genome sequence indicated the presence of a 
nan operon which not only contained the nanTA genes but also had several other genes involved in 
sialic acid metabolism as well as an upstream regulator. The divergently transcribed transcriptional 
regulator NanR is able to repress the expression of the nan operon in the absence of sialic acid. Since 
the completion of the genome, the genes included in the nan operon have been characterized in E. 
coli and a summary of their functions is outlined below. 
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Figure 2 - Bacterial sialic acid biosynthesis and subsequent surface modifications. Schematic outlining the pathways utilized by bacteria for sialic 
acid biosynthesis and modification previous to incorporation into PSA and LPS (Adapted from Severi et al, 2007). 
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Sialic acid biosynthesis 
 
 
Bacterial biosynthesis of sialic acid has evolved in two ways with some bacteria using a pathway for 
biosynthesis that differs to the eukaryotic method and others using truncated pathways which is 
reliant on host or environment derived sialic acid for sialylation (Fig. 2. Severi et al,2007). E. coli K1, N. 
meningitidis and other pathogens utilize the de novo sialic acid biosynthesis pathway, bacteria such as 
N. gonorrhea use a sialic acid scavenging pathway and H. influenzae scavenge precursors to obtain 
sialic acid for cell surface decoration(Almagro-Moreno and Boyd, 2009; Vimr et al, 2004; Severi et al, 
2007). 
 
 
The biosynthetic pathway for Neu5Ac was initially established in the 1960’s by the Roseman and 
Warren groups (Rosenberg et al, 1976). As reflected by sequence similarities of enzymes involved the 
process of Neu5Ac biosynthesis is similar in bacteria and vertebrates (Fig. 2). In vertebrates and 
higher invertebrates sialic acid biosynthesis takes place in the cytosol in four step process involving 
three enzymes (Li and Chen, 2012). Neu5Ac is synthesised by the condensation of a neutral six 
carbon unit and the three carbon molecules pyruvate. KOD is the only sugar that is synthesised in 
this way (Angata and Varki, 2002). 
 
The ultimate source of Neu5Ac is glucose with Neu5Ac synthesis beginning with the epimerization of 
N-acetylglucosamine (GlcNAc) to N-acetylmannosamine (ManNAc) (Angata and Varki, 2002). In 
veterbrates this process in catalysed by a bifunctional enzyme, UDP-GlcNAc/ManNAc kinase. This 
enzyme converts UDP-GlcNAc to ManNAc which is then immediately phosphorylated at the C6 
position to give ManNAc-6-P (Hinderlich et al, 1997; Stasche et al, 1997; Angata and Varki, 2002). 
The ManNAc-6-P is then condensed with phosphoenolpyruvate to give rise to Neu5Ac-9-P, a process 
that is catalysed by Neu5Ac-9-P synthestase (Lawrence et al, 2000; Nakata et al, 2000; Angata and 
Varki, 2002). The phosphate group is then removed by a specific phosphatase. 
 
In bacteria GlcNAc-6-P is epimerized to ManNAc-6-P by a GlcNAc-6-P 2-epimerase, in E. coli K1 this is 
encoded by the neuC gene and in N. meningitidis the siaA gene (Zapata et al, 1992; Petersen et al, 
2000; Angata and Varki, 2002). The ManNAc-6-P is then dephosphorylated. The ManNAc and a 
phosphoenolpyruvate are then condensed through the activity of a synthestase (NeuB in E. coli and 
SiaC in N. meningitidis) to yield Neu5Ac (Vann et al, 1997; Angata and Varki, 2002). 
 
In both bacteria and vertebrates the Neu5Ac is activated to CMP-Neu5Ac using cytidine 5- 
triphosphate (CTP). This process is catalysed by a cytosine 5’-monophosphate N acetylneuraminic 
acid (CMP-Neu5Ac) synthetase which is NeuA in E. coli and SiaB in N. meningitidis (Zapata et al, 
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1989; Edwards and Frosch, 1992; Angata and Varki, 2002). In vertebrates the synthesis takes place in 
the nuclei after which it is transported to the Golgi body via a CMP-sialic acid transporter where 
further modification and formation of glycoconjugates take place (Kean et al, 2004; Altheide et al, 
2006; Eckhardt et al, 1996). 
 
 
The CMP-Neu5Ac is added to Neu5Ac acceptor substrates by sialyltransferases. In mammals many 
different sialytransferases have been identified including ones for Siaα2-6Gal, Siaα2-3Gal, Siaα2-8Sia 
and Siaα2-6GalNAc linkages (Tsuji, 1996; Harduin-lepers et al, 1995). In bacteria a series of unrelated 
sialyltransferases have also been identified; α2-8(9) polysialyltransferases of E. coli K1/K92 and N. 
meningitides, α2-6 sialyltransferase of Photobacterium damsela, α2-3/6 sialyltransferase of N. 
gonorrhoeae, α2-3 sialyltransferase of Haemophilus. ducreyi and H. influenzae and α2-3 
sialyltransferase of C. jejuni (Steenbergen et al, 1992; Yamamoto et al, 1996; Gilbert et al, 1996; Bozue 
et al, 1999). 
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Figure 3 - Sialic acid 
biosynthesis. The sialic 
acid biosynthesis 
differs between 
bacteria and 
vertebrates during the 
initial stages of 
synthesis. 
Figure taken from 
Angata and Varki, 
2002.
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Bacterial sialic acid catabolism 
 
 
Over recent years an increasing number of bacterial pathogens and human commensals are being 
identified which are able to utilize sialic acid as a growth factor or sole carbon source (Corfield, 1992; 
Vimr et al, 2004; Severi et al, 2007). The pathway for sialic acid catabolism has been established in E. 
coli (Fig. 3). 
 
One of the first genes identified in the E. coli sialic acid metabolism pathway was the nanT. This has 
been established to code a secondary transporter of the major facilitator superfamily that can 
transport exogenous sialic acid. Once the sialic acid is successfully transported into the bacterial cell it 
is degraded intracellularly by NanA. NanA acts as an aldolase which breaks down the sialic acid into 
pyruvate and ManNAc. Evolutionary analysis shows that NanA has significant horizontal gene transfer 
between eukaryotes and prokaryotes. Of particular interest is that all members of Bacteroides have 
NanA proteins that branch closely to members of the eukarya (Almegro-Moreono 
and Boyd, 2009; De Koning et al, 2000). A kinase, NanK, then phosphorylates the ManNAc at the C-6 
position producing the substrate for an epimerase (NanE). NanE converts the ManNAc-6-P to 
GlcNAc-6-P which is then fed into the NagA/NagB pathway, eventually giving rise to fructose-6-P that 
can be used as a carbon source. NagA (N-acetylglucosamine-6-P deacetylase) removes an acetyle 
group from GlcNAc-6-P giving rise to Glucosamine-6-P (Glc-6-P). NagB (N-glucosamine-6-P deaminase) 
then removes the amino group from Glc-6-P leading to the production of fructose-6-P (Plumbridge and 
Vimr, 1999) 
 
Orthologues of the genes encoding NanAEK were initially regarded as essential requirements for a 
complete nan operon in those bacteria that are able to catabolise sialic acid. Although evidence 
suggests this is the case there is the potential that alternative methods exists for sialic acid catabolism, 
Although the final product of the sialic acid metabolism pathway is fed into the NagAB system, in E. coli 
the genes encoding these are not in close association with the nan operon. This holds true for most 
sialic acid catabolising bacteria with only a few exceptions. 
 
As well as the need for the enzymes involved in sialic acid catabolism, it is essential for bacterial cells 
utilizing sialic acid to have transporters. To date there are three main functionally characterized 
types of bacterial sialic acid transporters. Although there is a general consensus of genes required 
 
for catabolism of sialic acid, the method by which the sialic acid is transported from an extracellular 
location to an intracellular varies between bacterial species. 
 
Transport across the inner membrane has been studied in detail and four major classes of inner 
membrane transporters have been identified. NanT falls into the category of Major Facilitator 
Permeases whereas SiaPQM is a tripartite ATP-independent periplasmic (TRAP) transporter (Vimr et al, 
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2004; Steenbergen et al, 2005; Mulligan et al, 2012). More recently a third type of transporter has 
been identified. The Sodium Solute Symporter (SSS) family of transporters were first identified in 
Salmonella tymphimirium and is predicted to be present in many pathogenic bacteria (Severi et al, 
2010). In H. ducreyi there appears to be a novel transporter which falls into the ABC family of 
transporters (SatABCD), which are common in Gram positives including Corynebacterium 
glutamicum (Post et al, 2005; Grutser et al, 2012; Chowdhury et al, 2012). 
 
Outer membrane transporters for sialic acid fall into two main categories; NanC and NanOU. NanC 
was first identified in E. coli K12 and is a sialic acid specific porin. It was shown to be essential for 
bacterial growth on sialic acid in the absence of the more general porins OmpF and OmpC (Condemine 
et al, 2005). The NanOU transporter is coded by two individual genes (nanO and nanU) and is a TonB 
dependent transporter found in Tanerella forsythia (Roy et al, 2010). In association with this 
transporter there is also NanO which is part of the TonB dependent receptor family involved in small 
molecule transport and energized by a TomB-ExbB-ExbD complex (Xu et al, 
2003; Xu et al, 2007; Blanvillain et al, 2007). 
 
 
Alongside these sialic acid catabolic genes, accessory genes have also been identified. These aid the 
bacteria in scavenging and utilizing exogenous sialic acids. Neuraminidase or sialidase (NanH) is the 
first accessory gene that was identified to be involved in Neu5Ac scavenging. The accessory genes 
aid in utilizing exogenous Neu5Ac but are not present in all sialic acid catabolising bacteria (Almagro- 
moreno and Boyd, 2010). The majority of Neu5Ac is bound as terminal residues on glycolipids and 
glycoproteins thus making them inaccessible to the bacteria (Sillanaukee et al, 1999). To compensate 
for this, certain bacteria (excluding E. coli) are able to secrete a sialidase to promote cleavage of the 
glycoketosidic linkages producing free Neu5Ac (Vimr and Troy, 1985). These enzymes act as specific 
glycosidases that use a double displacement mechanism and a covalent glycosyl-enzyme intermediate 
(Newstead et al, 2008). Along with host sialidases, these secreted bacterial sialidases increase the 
Neu5Ac pool available for utilization by all bacteria in their niche. Bacteria encoding the nanATEK 
genes then use the free Neu5Ac as a carbon source or as decoration for their cell surface. Sialidases 
cleave terminal sialic acid residues linked in an alpha configuration to oligosaccharides, but underlying 
carbohydrate residues and modification on side chains of the sialic acid (such as addition acetyl 
groups) affect the activity of the sialidase (Achyuthan et al, 2001; Roggentin et al, 1993; Lewis and 
Lewis, 2012). For example in T. forsythia, NanH is only able to cleave α-2,3-sialyl and α-2,6-sialyl bonds 
(Thompson et al, 2009; Stafford et al, 2011). As well as releasing sialic acid, bacterial sialidases are also 
involved in unmasking toxin receptors (exemplified by V. cholera) and biofilm formation (as 
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seen in P. aruginosa) (Holmgren et al, 1975; Soong et al, 2006). These enzymes are also able act as 
adhesins in their own right as well as exposing adhesive epitopes (Stafford et al, 2011). 
 
In many pathogenic bacteria it has been shown that sialidases not only contain a catalytic domain for 
the release of sialic acid, but also contain carbohydrate binding domains (CBM) at either the C- or N-
terminal of the sialidase. These CBM domains have also been identified incorporated within the β- 
propeller domain of the sialidase. It is postulated that these additional domains increase sialidase 
activity, especially in the presence of polysaccharides (Varghese et al, 1983; Crennell et al, 1993; 
Crennell et al, 1994; Park et al, 2013). It is interesting to note that in B. thetaiotamicron, a gram 
negative anerobic commensal of the gut, the N-terminal CBM found on its sialidase has a lectin like 
fold that differs from those previously described (Achyuthan et al, 2001; Xu et al, 2008; Boraston et al, 
2007; Park et al, 2013). 
 
A sialic acid mutarotase (NanM) has also been identified in E. coli and is associated with the 
successful utilization of Neu5Ac by bacteria. When bound to sialoglycoconjugates the Neu5Ac is 
found in its α-anomer form, bacteria however utilize Neu5Ac in the β-anomer form (Severi et al, 
2008; Amegro-Moreono and Boyd, 2010). The alpha and beta configuration refers to the C7 and C1 
carboxyl groups in either axial or equatorial orientations respectively (Angata and Varki. 2002). The 
pool of free Neu5Ac exists in a state of equilibrium where 95% of the Neu5Ac is found as a β- 
anomer. Spontaneous mutarotation of free α-Neu5Ac to β-Nue5Ac occurs at a slow rate. NanM is 
able to increase the rate at which this mutarotation occurs to reach equilibrium levels (Severi et al, 
2007). 
 
 
In the gastrointestinal tract (GI) many of the Neu5Ac molecules on the epithelial cell surfaces and 
mucin proteins have additional O-acetyl groups. Recently a novel enzyme has been identified in E. coli 
with sialate-O-acetylesterase activity (Rangarajan et al., 2011).This enzyme, now called NanS, is able 
to cleave the O-acetyl group and is found at a cytoplasmic location in E. coli (Thomas et al, 
unpublished). The molecular characterization of a sialate O-acetylesterase is of particular interest as 
changes in levels of gut epithelial acetylated sialic acids are associated with GI cancers. Mutations in 
the human sialate-O-acetyltransferase, that lead to a decrease in sialic acid acetylation, are thought 
to be an important factor in the progression of GI cancer (Corfield et al., 1999). Human faecal extracts 
have been found to contain extracellular sialate-O-acetylesterase activity which is thought to 
correlate to the presence of bacteria from the Bacteroides genus, where the NanS is potentially 
secreted and converts the acetylated sialic acid back to Neu5Ac, which can then be cleaved from the 
glycan via the action of the bacterial sialidase NanH (Corfied, 1993). 
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Figure 4 – Catabolism of Neu5,9Ac2 by Escherichia coli. Di-acetylated sialic acid is de-acetylated to 
allow α-Neu5Ac release from its glycan bound state by the action of NanH. NanM increases rotation 
rate of α-anomer to the β-anomer which can then be transported through the outer membrane by 
NanO/U and through the inner membrane by NanT. Once inside the cell an unknown mechanism 
rotates the β-Neu5Ac back to the α-form in preparation for NanA action. Once NanA cleaves the 
Neu5Ac into ManNAc and Pyruvate the pathway can take one of two routes. In E. coli NanK 
phosphorylates the ManNAc as the NanE requires a phosphorylated substrate for conversion to 
GlcNAc. 
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Sialate-O-acetylesterase 
 
Acetylation and deacetylation of both N- and O-acetylated carbohydrates is a common occurrence in 
nature. Enzymes involved in the deacetylation of carbohydrates fall into 16 groups of carbohydrate 
hydrolases and are further separated into two functional classes of enzymes: those that remove acetyl 
groups from carbohydrate units of polysaccharides (including pectin, xylan, conjugated sialic acids and 
others) as part of a catabolic pathway and those that are associated with regulation or virulence 
functions (Sundberg and Poutanen, 1991; Corfield et al, 1992; Steenbergen et al, 2009; Vimr and 
Steenbergen, 2006). Many of these enzymes have a broad substrate specificity including a range of 
naturally occurring and synthetic substrates (Rangarajan et al, 2010). 
 
Sialate-O-acetylesterases known as NanS in bacterial cells belong to the SGNH superfamily of 
hydrolases (Molgaard et al, 2000). This superfamily is a distinct class of α/β hydrolases which are 
based on the presence of a catalytic serine (S), an oxyanion hole forming residue glycine (G), an 
asparagine (N) and an invariant histidine (H) (Ollis et al, 1992; Lo et al, 2003). Each of these residues 
is found within blocks of conserved residues in all SGNH hydrolases regardless of catalytic function 
with each member of the group utilizing a nucleophilic-His-acid catalytic triad for hydrolysis of its 
given substrate (Rangarajan et al, 2010). The conserved residues were shown to be incorporated into 
four distinct blocks within the SGNH hydrolases. Block I contains a GDS motif with the nucleophilc Ser 
residue and a hydrogen bond donor for the oxyanion hole. Block II contains the conserved Gly while 
Block III contains the conserved Asn which is involved in the formation of the 
oxyanion hole within a conserved GXN motif. Finally Block IV has two catalytic residues, aspartic acid 
and histidine, within a DXXH motif (Rangarajan et al, 2010). 
 
Structural analysis shows the SGNH hydrolases to contain a central, five stranded parallel β-sheet 
which is flanked by an α-helix on either side. The nucleophile is shown to sit on the sharp turn 
between the β-strand and the leading α-helix. The His sits within the loop preceding the C-terminal 
α-helix with the aspartate (part of the catalytic triad) found two residues previous to the His. This 
makes the SGNH hydrolase family distinct from other hydrolases where it is the aspartate that 
follows the His (Rangarajan et al, 2010). 
 
In E. coli the sialate-O-acetylesterase was actually initially thought to be an acetylxylan esterase but 
has since been shown to specific for 9-O-acetylated Neu5Ac and is essential for growth of E. coli on 
sialic acid (Steenbergen et al, 2009). The nanS gene in E. coli is found within the operon also 
containing nanC and nanM (Houliston et al, 2006). The E. coli NanS protein is found as a monomer in 
solution and has a single compact domain that is similar to the conical α/β hydrolase fold and in 
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specific the SGNH hydrolyse fold (Molgaard et al, 2000; Rangarajan et al, 2010). It is comprised of a 
seven stranded mixed β-sheet and two β-hairpins following the β-2 and β-6 strands. Both C- and N- 
terminal α-helices are situated on the concave side of the β-sheet with the rest sitting on the convex 
side (Rangarajan et al, 2010). 
 
Although the backbone of NanS is similar to the SGNH hydrolases previously characterized, it became 
the founding member of a sub-group of the family (now known as Group II SGNH hydrolases) due to 
differences observed in comparison to those previously described. These differences are observed 
within the conserved blocks described above. Block I of Group II hysrolases contains a GXSN 
conserved region as appose to the GDS motif seen in Group I SGNH hydrolases. The glutamate in this 
conserved motif (Gln18 in NanS), which is adjacent to the catalytic serine (Ser19), functions as a 
hydrogen bond donor for the formation of the oxyanion hole and so functionally replaces the 
asparagine found within the Block III GXN motif in Group I SGNH hydrolases. In addition to this the 
Block III motif is replaced by a QGEX conserved sequence, where the residues act to stabilise the 
Gln18. Interestingly the Asp found in Block IV of the Group I SGNH hydrolases is not present within 
the Group II hydrolases (Rangarajan et al, 2010). Although the E. coli NanS falls into a distinct sub-
group of the SGNH hydrolase family, not all prokaryotic esterases do (Lewis et al, 2007; Steenbergen 
et al, 2006). The mammalian sialate O-acetylesterase, interestingly, does fall into the group II sub-
group of SGNH hydrolases. 
 
The presence of a mammalian sialate O-acetylesterase was first predicted in 1985 when it was 
suggested that the esterase existed in a membrane bound form (Varki et al, 1985). At this time little 
was known about the catabolism or turnover of the O-acetyl group found on sialic acids. In 1989 
experimental data showed the presence of the acetylesterase within the rat liver. Golgi vesicles 
containing 3H- labelled acetyl were shown to incorporate a large portion of the labelled compound 
into acetylated sialic acid. When this was incubated with neurominidase a significant amount of free 
labelled acetate was detected, indicating the presence of an esterase within the Golgi vesicle (Higa et 
al, 1989). 
 
Since their initial identification, it has been shown that two isoforms of the mammalian sialate O- 
acetylesterases exist. Both forms of the acetylesterase in mammals are coded by an individual gene 
but expressed differently in various tissues and have different subcellular localization (Takematsu et 
al, 1999). Of the two forms one is found localized in the cytoplasm and the other in lysosomal 
compartments. The lysosomal acetylesterase contains a predicted signal peptide and is through to 
participate in the deacetylation of 9-O-acetylated sialoglycoconjugates. The cytosolic isoform, 
however, contains no signal peptide and is thought to salvage any acetylated molecules that escape 
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the initial action of the lysosomal esterase (Higa et al, 1989; Butor et al, 1992; Guimaraes et al, 1996; 
Takematsu et al, 1999; Schauer et al, 1989). Following identification of these acetylesterases in rats 
and mice, the first indication of the presence of lysosomal sialate acetylesterase in human tissue was 
shown in 2003. The human sialate acetylesterase (SIAE) was shown to structural similarities to those 
previously identified in mice and rats (Zhu et al, 2003; Yangin et al, 2004). 
 
Project objectives 
 
An intimate relationship has been established between sialic acid catabolism and bacterial fitness in 
the gut due to this prevalence of sialic acid in this environment (Almagro-Moreo and Boyd, 2009; Jong 
et al, 2009; Chang et al, 2008). The human intestine is dominated by two phyla of bacteria, the 
Bacteroidetes and the Firmicutes. These account for 95 to 98% of the microbiota but the relative 
abundance of each varies. Bacteroides (Gram-negative, nonsporing, rod shaped bacteria) are the 
most abundant in the gut microbiota and corresponding to 25% of all intestinal bacteria (Karlsson et 
al, 2010; Eckburg et al, 2005). 
 
The aim of the project is to determine if gut commensals have the potential to alter levels of 
acetylated sialic acid on the host cells surface, through identification and characterisation of 
Bacteroides sialate O-acetylesterase activities. 
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Materials and Methods 
 
 
 
Media 
 
 
Preparation of liquid and agar media was achieved by dissolving the specific quantities in distilled 
water and autoclaved at 121°C and 15 Psi. Approximately 20 ml of liquid agar was poured into Petri 
dishes for the preparation of agar plates. These were dried in a category 2 microbiology cabinet 
before storage at 4°C. 
 
For the preparation of Lauria Broth (LB) 20 g of tryptone, 10 g of yeast extract and 10 g of NaCl was 
dissolved in a total volume of 1 litre of dH20. For agar media 5 g agar was added to the above mix. 
 
Media was infused with appropriate antibiotics at the following concentrations. Ampicillin 100 μg/ml 
and Kanamycin 30 μg/ml 
 
Polymerase Chain Reaction (PCR) 
 
 
PCR was performed as previously described (Mullis et al, 1986). Primers were designed and purchased 
from MWG Biotech (Germany). Each primer was diluted as per manufactures instructions to give a 
final concentration of 100 pm/μl. Primers sequences are described in Table 1. dNTP stock was 
prepared to a final concentration of 2.5mM. 
 
For Taq polymerase PCR the following 50 μl reaction mix was prepared in a 0.5 ml PCR tubes; 5 μl of 
 
10x Thermo. Polymerase buffer (NEB), 1 μl dNTPs (of a 10 mM stock), 5 μl forward and reverse 
primers (from a 10 pm/μl stock), 1 μl of genomic DNA, and dH2O to make up the final volume. For 
whole cell PCR, a colony from an agar plate was resuspended in the above mix in place of the 
genomic DNA. 
 
For KOD hot start polymerase PCR the following 50 μl reaction mix was prepared; 5 μl of 10x conc. 
KOD hotstart buffer, dNTPs (10mM final concentration), forward and reverse primers (10 pMol/μl final 
concentration), MgSO4 (20mM final concentration), 1 μl of genomic DNA, and dH2O to make up the 
final volume. 
 
Using a thermocycler, PCRs were performed with an initial denaturing at 95 °C for 5 minutes and 
subsequent denaturing at 94 °C for 30 seconds. Annealing was carried out to an appropriate 
temperature and time for the given primer set. Extension and final extension were both done at 72 
°C for 3 minutes and 5 minutes respectively, and the completed reaction held at 10 °C. 
25 
 
Agarose gel electrophoresis 
 
 
 
The product of PCR reactions and restriction enzyme digests were analysed through electrophoresis 
of the DNA samples using a 1% agarose gel. A stock solution of 10x TBE was made as follows: 2.5 L 
dH2O, 405g Tris, 68.75 g Boric acid and 23.75 g EDTA. The 1% agarose gel was made up in 100 ml of 
1x TBE. 10 μl of Sybersafe or 10 μl ethidium bromide was added to molten agarose before 50 ml of the 
agarose was allowed to set in a gel tank containing well combs. 10x conc. Loading buffer was added to 
each sample before samples were loaded into the wells. The gel was run in 1x TBE buffer at 
80V for approximately 40 minutes. DNA was visualized using a Transilluminator. 
 
 
Restriction enzyme digests 
 
 
Both pBAD and pET vectors were digested using either Swa1 or BseR1 respectively for cloning for 
subsequent ligation independent cloning. The purified plasmids were digested in a total volume of 
60 μl containing the following; 50 μl purified plasmid (pBAD vector was purified to (4.4 ng/μl and the 
 
pET vector was purified to 16.3 ng/μl) 1 μl restriction enzyme, 6 μl 10x buffer and 4 μl dH2O. For the 
digestion of pET vectors buffer 4 (NEB) was used and samples were incubated at 37 °C for 2 hours 
before enzyme inactivation at 65 °C for 20 minutes. Digestion of pBAD vectors used buffer 3 (NEB) 
and incubation was carried out at 25 °C for 2 hours before enzyme inactivation. 
 
For determination of insert orientation and presence in traditional expression vectors (pET and 
pBAD), restriction enzyme digests was carried out using two enzymes (as outlined in Table 2). The 
total reaction volume was 20 μl and consisted of 5 μl of the purified construct, 1 μl of each enzyme, 
2 μl of the appropriate 10x buffer and dH2O to make up the final volume. Reaction conditions are 
 
outlined in Table 2. 
 
 
For the screening of insert presence in novel vectors the following components were included in a 
 
total reaction volume of 20 μl; 16 μl of the purified plasmid, 1 μl Xho1, 1 μl Nco1, 2 μl buffer 4 and 
 
0.2 μl BSA. The reactions were incubated at 37 °C for 2 hours before DNA was visualised on an 
 
agarose gel.
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SDS-PAGE 
 
 
SDS-PAGE was performed for analysis of protein expression, solubility and purification. Whole cell 
samples were resuspended in 25 x b μl 5x loading dye (12.6 % stacking buffer [20 mM TRIS and 0.55 
mM SDS, pH 6.8], 10.5 % glycerol, 2.1 % SDS, 0.005 % bromophenol blue and 5 % 2- mercaptoethanol) 
where b is the OD of the cell culture at the point of harvest. In the case of non- whole cell samples 
used in the SDS assay, 10 μl of the sample was added to 10 μl of 5x loading dye. Samples were boiled 
for 5 minutes and loaded onto a 12 % SDS polyacrylamide gel. Samples loaded onto the gel were 
separated at 200 V in running buffer (25 mM TRIS, 250 mM Glycine and 0.1 % SDS) until the gel front 
was between 1 and 5 mm from the bottom. Gels were stained in bromophenol blue to visualise 
proteins. 
 
Bioinformatics 
Analysis of gene and protein sequences was achieved using Blast searches, Xbase and Uniprot. Genes 
previously established as being involved in sialic acid metabolism were used as Blast queries for the 
identification of homolgous genes within Bacteroides. Gene maps were constructed using Xbase and 
Uniprot for size and orientation of the Bacteroides genes. Sequence alignments were constructed 
using Clustal X which was also utilized to construct trees analysing relationships between various NanS 
proteins from different bacterial species (Fig. 16).  
27 
 
 
 
 
 
 
Gene Vector Forward Primer Reverse Primer 
BT_0457 pETYSBL 
IC-3C 
CCAGGGACCAGCAATGCAGGAAAAT 
CGTATTAAAG 
GAGGAGAAGGCGCGTTATCATTTCATCG 
AAAATTCG 
BT_0447 pETYSBL 
IC-3C 
CCAGGGACCAGCAATGTTCAGAAAC 
AGATACT 
GAGGAGAAGGCGCGTTATCATAAGGAG 
CCTCCTCTT 
BT_0457 pBADcLI 
C 
ATGGGTGGTGGATTTGCTATGATGA 
AAAATGTATTAT 
TTGGAAGTATAAATTTTCTTTCATCGAAA 
ATTCGGCA 
BT_0447 pBADcLI 
C 
ATGGGTGGTGGATTTGCTATGTTCAG 
AAACAGATACT 
TTGGAAGTATAAATTTTCTAAGGAGCCT 
CCTCTTTTC 
BT_0457 
Full 
length 
pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGCAGGAAAA 
TCGTATTAAAGTTGC 
TGAGGAGAAGGCGCGTTATTTCATCGA 
AAATTCGGCACG 
BT_0457 
DUF303 
domain 
pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGTTCATATTG 
ACGGACGCCGTACACC 
TGAGGAGAAGGCGCGTTATTTCATCGA 
AAATTCGGCACG 
BT_0457 
N- 
terminal 
pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGCAGGAAAA 
TCGTATTAAAGTTGC 
TGAGGAGAAGGCGCGTTACATATTGTC 
TGTATAAAGC 
BT_0447 
Full 
length 
pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGTTCAGAAA 
CAGATACTTTTGGC 
TGAGGAGAAGGCGCGTTATAAGGAGCC 
TCCTCTTTTCATTCC 
BT_0447 
DUF303 
domain 
pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGTTCAGAAA 
CAGATACTTTTGGC 
TGAGGAGAAGGCGCGTTAAAGGCCGG 
TTTCTTTTTGATCACG 
BT_0447 
C- 
terminal 
pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGAAAAAGAA 
ACCGGCCTTAATGTGG 
TGAGGAGAAGGCGCGTTATAAGGAGCC 
TCCTCTTTTCATTCC 
BT_4091 pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGCAAGTGAA 
ATTGCTTCCG 
TGAGGAGAAGGCGCGTTATTTATTGAC 
ATAAGTAATACCTTTCC 
BT_0895 pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGGAAGTGAA 
ACTGCCCGCTATTTC 
TGAGGAGAAGGCGCGTTACCAATCGTC 
CGAACGGAAAGACC 
BT_3171 pETFPP_ 
2/3/4/5 
TGAGGAGAAGGCGCGTTACCAATCG 
TCCGAACGGAAAGACC 
TGAGGAGAAGGCGCGTTACTTTACATC 
ATCCCATGTATCC 
BT_4180 pETFPP_ 
2/3/4/5 
TCCAGGGACCAGCAATGGAGAAACC 
GCTGAAGACTCTGG 
TGAGGAGAAGGCGCGTTATTTCTTTATT 
AGTTTCTTAAC 
 
 
 
Table 1- Primer list. List of primers utilized during the course of this study. Primers for cloning into 
conventional vectors were designed to incorporate the Ligation Independent Cloning (LIC) cassette 
(Bold). Primers designed for utilization with the novel cloning vectors were designed to include a 
vector complementary sequence in the final PCR product for downstream InFusion cloning. 
28 
 
 
 
Preparation of pBADcLIC and pETYSBLIC3C based vectors 
 
 
Genes of interest (BT_0447 and BT_0457) were initially cloned for insertion into the conventional 
vectors used in the Thomas Lab. These are the pETYSBLIC3C vector and the pBADcLIC vector. In all 
cases the primers were designed to include the LIC cassette as well as cloning the gene of interest 
(Table 1). 
 
Both pET and pBAD vectors were prepared for cloning through restriction enzyme digestion with 
enzymes BSer1 and Swa1 respectively. Following vector digestions, products were run on a 1% 
agarose gel and bands migrating to the correct molecular weight were extracted and purified using a 
gel extraction kit (Macherey – Nagel). Purified digested vectors were then prepared for Ligation 
Independent cloning (LIC). This was achieved by treating 45 μl of the vector with 9 μl dTTP at a final 
concentration of 25 mM (for pET vectors) or 9 μl dCTP at a final concentration of 25 mM (for pBAD 
vectors). The reaction was carried out in a total volume of 62.5 μl and also contained 6 μl of 10x T4 
DNAse polymerase buffer. The reaction mix was incubated at room temperature with 2.5 μl T4 DNA 
 
polymerase for 30 minutes before inactivation of the polymerase by incubation at 75°C for 20 
minutes. To determine if the digest and LIC preparation was successful, the resulting DNA was 
transformed into Solopack Gold supercompetent E. coli (Invitrogen) cells (as per manufacturer’s 
instructions). Addition of the LIC cassette interferes with antibiotic resistance and so a lack of 
colonies on a transformation plate containing the appropriate antibiotic correlates to the plasmids 
with the LIC cassette. 
 
BT_0447 and BT_0457 were both amplified from B. thetaiotamicron genomic DNA by PCR using a high 
fidelity KOD polymerase, with an annealing temperature of 55°C and using primers described in Table 
1. The PCR products were seperated on a 1% agarose before the bands representing the PCR products 
were extracted and purified using the a gel extraction kit. A volume of 14 μl purified PCR products 
were treated in the same way as the vectors for LIC annealing by the addition of 2 μl dATP at a final 
concentration of 25 mM (for genes being cloned into the pET vector) or 2 μl dGTP at a final 
concentration of 25 mM (for genes being cloned into the pBAD vector). In this case the reaction mix 
also contained 1 μl 100 mM DTT as well as 0.5 μl T4 DNAse polymerase and 2 μl T4 polymerase buffer. 
 
Insertion of the genes of interests into LIC ready vectors was achieved through LIC annealing at a 1:2 
molar ratio of vector to insert. Reactions were incubated at room temperature for 20 minutes 
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before the addition of 1.5 μl 25 mM EDTA and a further incubation for 15 minutes. Resultant 
 
products were then transformed into Solopack Gold supercompetent E. coli cells. 
 
 
Colonies present following transformation were analyzed using Taq polymerase PCR and primers used 
for cloning. Successful transformation was established by presence of a band on an agarose gel with a 
molecular weight representing the gene of interest. Colonies producing positive results for each 
transformation were then used to inoculate 5 ml of LB (containing appropriate antibiotics) followed 
by overnight incubation at 37°C. Overnight cultures were then used for purification of plasmid 
constructs using a Nucleo-spin plasmid mini prep kit (Macherey - Nagel). Correct plasmid orientation 
and insertion was checked through restriction enzyme digests of the purified plasmid constructs 
(Table 2). 
 
Preparation of plasmids based on novel pET vectors 
 
 
Due to insolubility of proteins using the standard cloning method an alternative approach was taken 
to produce soluble proteins. This approach relied on the InFusion cloning method and a range of 
vectors engineered in the Protein production lab of the York Technology Facility (TF) by Jared 
Cartwright to facilitate rapid cloning into a pET-based vector to create fusions with MBP (pETFPP_2), 
GST(pETFPP_3), IM9 (pETFPP_4) or GFP (pETFPP_5) and improve solubility. 
 
Achieving In-Fusion cloning involved designing primers which not only amplified the gene of interest 
during the PCR process, but also incorporated vector complimentary regions flanking the gene in the 
final PCR product. The vectors were treated by the TF with BseR1 to produce these overhangs for 
which the adaptors on the PCR products are complementary. During the In-Fusion ligation 
independent cloning process, the In-Fusion enzyme (Clontech) then anneals the complementary 
sequences and inserts the gene of interest at the specific position within the vector. 
 
Each target was amplified from genomic DNA using a high fidelity PCR process with KOD polymerase 
at an annealing temperature of 52 °C. Successful PCR was determined through analysis on an 
agarose gel and the total PCR reaction mix was treated with 1 μl Dpn1 for 1 hour at a temperature of 
 
37 °C. Treated PCR products were analysed on an agarose gel and correct bands were gel extracted 
and purified using a gel extraction kit. 
 
1 μl of the PCR product was then incubated with 1 μl of the digested and treated vector at 37 °C in 
the presence of 2 μl of the InFusion enzyme. The reaction was incubated for 15 minutes before the 
enzyme was heat inactivated by incubation at 50 °C for 15 minutes. Following InFusion cloning the 
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resultant plasmids were transformed into XL1-blue supercompetant cells and insert presence was 
determined through colony screening. 
 
Transformation into XL1-blue supercompetant cells was achieved as follows: 10 μl of XL1-blue cells 
were thawed on ice for 10 minutes before 1 μl of the purified plasmid construct was added to the 
cells. The cells were gently mixed before being left on ice for a further 10 minutes. The samples were 
then heat shocked at 42 °C for a total of 30 seconds and then allowed to recover on ice for 2 
minutes. 100 μl of LB was then added to the cells and samples were incubated with shaking at 37 °C 
 
for 1 hour. The resultant samples were then plated on kanamycin selective LB plates which were 
incubated at 37 °C overnight. 
 
Any colonies present of antibiotic selective plates were used to inoculate 5 ml LB and grown overnight 
at 37 °C. Plasmids were then purified from the cultures using a plasmid mini prep kit and a restriction 
enzyme digest with Xho1 and Nco1 was carried out to determine correct insertion of gene of interest 
into the vectors. This was analyzed on a 1% agarose gel. Each of the 10 targets were cloned into 4 
different vectors and a series of 40 constructs created. 
 
Cell growth for protein expression trials 
 
 
Plasmids were initially transformed into either Solopackgold competent cells (during the 
conventional cloning process) or XL1-blue super competent cells (for the alternative cloning 
methods). Following transformation colonies grown on antibiotic selective plates were picked and 
screened (through purification and restriction enzyme digests or whole cell PCR) for correct insert 
presence. These purified plasmids were then transformed into MC1061 cells (for pBAD based 
plasmids) or BL21 cells (for pET based plasmids). 
 
Following successful transformation into E. coli expression strains, colonies were picked and used to 
inoculate 5 ml LB. These starter cultures were allowed to grow overnight at 37°C before being used to 
inoculate 25 ml LB to an OD650 of 0.05. 25 ml cultures were then incubated at either 20, 30 or 37 
°C with shaking until they reached an OD650 between 0.4 and 0.6 at which point expression of the 
 
recombinant genes were induced with 0.2 mM isopropylthiogalactoside (IPTG) (pET vectors) or 
 
0.005% arabinose (pBAD vectors). 
 
 
During expression from conventional vectors 1 ml samples for protein expression analysis were taken 
every hour for 3 or 4 hours and after 24 hours. When proteins were expressed from the pET vectors 
containing the fusion partners, cultures were grown at 20 °C before and after induction and 
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were harvested after overnight growth for expression trials. Protein expression was analysed using 
 
SDS PAGE as described above. 
 
 
Solubility tests 
 
Once proteins were expressing correctly from the conventional vectors, three hour cell pellet samples 
were re-suspended in 200 μl of Bugbuster (Novagen). The samples were incubated at room 
temperature for 20 minutes before the addition of 100 μl of a phosphate buffer. After a further 10 
minute incubation samples were centrifuged for 1 minute and 10 μl of clear lysate was added to 
SDS-PAGE loading dye. These samples were boiled at 95 °C and analysed using SDS-PAGE. 
 
 
In the case of expression and solubility from novel vectors, cells were initially lysed using Bugbuster as 
described above but lysis was also achieved through the use of a detergent based lysis buffer. The cell 
pellets were resuspended in lysis buffer (50 mM HEPES, 100 mM KCl, 15 mM NaCl, 10 mM 
MgCl2, 10 mM CaCl2, 0.5 % [W/V] glycerol, 1 mg/ml lysozyme, 20 μg/ml DNAse and 0.5 % Triton 
X100) and incubated with agitation for 1 hour. These samples were then analyzed as described 
above. 
 
Protein purification 
 
Starter cultures were grown for 6 hours before being used to inoculate 25ml cultures. These were 
allowed to grow at the appropriate temperature overnight with shaking and were then used to 
inoculate large volumes (600ml or 800ml) to an OD650 of 0.05. Cultures were grown to mid log phase 
and induced as described previously. Cells from these cultures were harvested by centrifugation at 
5000 rpm and 4°C for 30 minutes. 
 
 
Following harvest cells were lysed in lysis buffer, centrifuged at 5000 rpm for 20 minutes at 4 °C and 
proteins purified from the clear lysate using nickel affinity chromatography via a HisTrap column. The 
5 ml HisTrap column was initially equilibrated by running approximately 25 ml equilibration buffer (50 
mM Tris, 200 mM NaCl, 20% Glycerol, 5 mM Imidazole) down the column using a peristaltic pump. 
The clear lysate sample was then run down the HisTrap column to allow binding of the protein His tag 
to the nickel within the column. The resultant wash through was collected and stored for analysis. 
Following this, non-specifically bound protein was removed using approximately 
100 ml (amounting to 20 column volumes) wash buffer (50 mM Tris, 200 mM NaCl, 20% Glycerol, 20 
mM Imidazole) down the column. The wash through was also collected and stored for analysis. Once 
the non-specific protein binding was eliminated an elution buffer (50 mM Tris, 200 mM NaCl, 20% 
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Glycerol, 500 mM Imidazole) was run through the column and 10 samples at volumes of 4 ml were 
collected. Each of the elution fractions were analysed using SDS-PAGE and fractions containing the 
protein of interests were dialysed over three hours in 50 mM Tris HCL buffer (pH6.8). 
 
Acetylesterase assay 
 
 
All enzyme assays were carried out in 1 ml cuvette. 0.5 μM of the protein (See Table 2 for volumes) 
was added to sodium phosphate buffer at pH 6.7 (at a final concentration of 20 mM). These samples 
were incubated at 40 °C for 10 minutes. Following this pre-incubation 0.5 mM of p-nitrophenyl 
acetate (pNPA) was added to each cuvette. The absorbance at OD405 was measured immediately after 
addition of substrate and then every 5 minutes for 30 minutes. In between readings samples were 
kept at 40 °C. 
 
In addition to assaying the purified proteins of interests a control assay was also carried out using 
various concentrations of an acetylxylan esterase from Orpinomyces sp. (Megazyme). 1 mM stock of 
PNPA was made by diluting 100 mM PNPA (dissolved in methanol) in sodium phosphate buffer (pH 
6.7). 
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Protein 
 
 
Molecular 
 
Weight 
 
 
Extinction 
co-efficient 
A280 of 
 
1 ml 
purified 
protein 
 
 
Concentration in 
 
μM 
 
Volume required 
for 0.5 μM final 
concentration 
BT1full- 
 
MBP 
 
119695.8 
 
215480 
 
4.64 
 
21.53 
 
23.2 μl 
BT1ext- 
 
MBP 
 
72506.3 
 
98335 
 
0.288 
 
2.93 
 
170.6 μl 
BT2ext- 
 
GST 
 
757773.6 
 
148435 
 
0.275 
 
1.85 
 
270.3 μl 
BT4-Im9 65144.6 121155 0.170 1.40 357.1 μl 
BT6-Im9 41796.4 52620 0.748 14.22 35.2 μl 
 
 
 
Table 2 - Concentrations of proteins for enzyme assays was determined using a calculated 
extinction co-efficient. 
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Results 
 
Comparative analysis of sialic acid catabolism genes across the Bacteroides genus 
 
 
Through the sequencing of many hundreds of bacterial genomes and the analysis of their gene 
content and layout, it has been shown that the nan operon has a complex genetic organisation in 
different organisms. The observation that the operons have very limited synteny is observed in both 
Gram positive and Gram negative bacteria, suggesting independent evolution of the operon structure 
prompted by the need to adapt to various environments (Vimr et al, 2004). It is logical to assume 
commensals of the human GI, an environment rich in sialic acids, might contain the appropriate genes 
for sialic acid utilization. 
 
Using this assumption and the available Bacteroides genome sequences in the public databases, the 
presence of the nan operon across the genus as well as positioning of nanS in relation to the other 
genes was established. To achieve this a series of Blast searches, using T. forsythia, E. coli, H. 
influenzae and B. fragilis nan genes as search queries, were used to establish the presence of potential 
sialic acid catabolism genes within the Bacteroides. Blast results were then used to construct gene 
maps of all the species investigated using Xbase and Uniprot for gene orientation and positioning (Fig. 
5). 
 
From the analysis it was evident that very little consistency existed in the gene layout between the 
different species investigated. As expected, most of the species investigated contained the nanAET 
genes together when all three were present in the genome. This appeared to be the only consistency 
observed between the different species. An exception to this general layout was observed in B. 
uniformis which contained a nanA within one cluster and the nanE within a second. Interestingly in 
B. uniformis there appeared to be no direct homologue of the nanT transporter observed in other 
species. There was, however, a gene encoding a member of the MFS transporter family adjacent to 
the nanE gene. When looking specifically within Bacteroides the closest homologue for the protein 
encoded by this gene was annotated as a sugar:proton symporter. In many Bacteroides these 
homologues are annotated as arabinose:proton symporter. A wider BLAST search showed that 
homologues of the protein observed in B. uniformis was seen across many different bacterial genus 
with the closest match seen in Dysgonomonas gadei (a member of the Bacteroidetes phylum) with a 
maximum sequence identity of 68% and Prevotella oralis (also belonging to the Bacteroidetes phylum) 
with a maximum sequence identity of 63%. 
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Like that seen previously in B. fragilis, a select few of the species had the genes involved in sialic acid 
utilization spread across two clusters. Similar to the gene organization observed in B. fragilis, when 
the genes were seen to be spread across two clusters, one cluster contain the essential catabolic 
genes nanAET while the other cluster included the accessory genes (such as nanH and nanS) as well as 
the outer membrane transporter, nanO and nanU. As described previously the exception to this was 
observed in B. uniformis where the catabolic genes were spread across the two clusters. 
 
In some instances where genes are spread across two clusters, multiple copies of certain nan genes 
was observed. Multiple examples were observed where two copies if the nanH genes were spread 
across two of the clusters. Parabacteroides merdae not only contained two nanH genes but is the 
only species investigated that has two nanA genes within each of its sialic acid metabolism clusters. 
 
During the analysis only a single example arose, in B. thetaiotamicron, where two nanS genes were 
observed within the same sialic acid catabolism gene cluster. This is of particular interest as the B. 
thetaiotamicron nan operon although containing accessory genes for sialic acid scavenging, lacks one 
of the essential catabolism genes. The cluster contains the nanE gene but lacks both the nanA and 
nanT genes, meaning B. thetaiotamicron is unable to transport the sialic acid into the cell and unable 
to convert the Neu5Ac to ManNAc. 
 
Many of the nan genes are also separated by genes involved in sugar utilization on a more general 
scale. This is exemplified in B. fluxus where the main catabolic genes are separated from the 
accessory genes by genes mainly denoted as glycosyl hydrolases. In addition to the presence of the 
glycosyl hydrolases, the genes involved in sialic acid catabolism in Bacteroides were also separated 
by acetylhydrolases, β-mannosidases, β-acetylhexosaminidases, fucosidases and mannosidases. 
 
The most interesting observation was seen when analyzing exceptionally long protein sequences, 
which not only resulted from NanS blast queries but also showed homology to E. coli NanM. Analysis 
of these sequences showed them to potentially be a fusion protein which could function as both a 
NanS and a NanM. The protein size correlated with a fusion between the two and the conserved 
sequences required for functionality of both proteins was easily identified following alignment studies. 
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Figure 5 - Sialic acid utilization genes in various Bacteroides species (to scale). The colouring of individual 
genes is indicated in the key. 
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Analysis of nanS genes in the Bacteroides clusters 
 
 
The presence of putative sialate-O-acetylesterase in Bacteroides was investigated further following 
the construction of the gene maps. Analysis showed in most cases that a candidate nanS gene was 
present adjacent to other accessory genes, in particular nanH and nahA. 
 
The NanS proteins were also aligned from various sources to investigate sequence identity between 
the different NanS proteins. When aligned with E. coli NanS there appeared to be very limited 
sequence identity with a large number of gaps in the E. coli protein sequence and very little 
conservation between the two species (Fig. 5A). During Blast searches using the E. coli NanS as a 
query the maximum sequence identity observed between a hypothetical Bacteroides protein and the 
E. coli NanS was a maximum of 34%. 
 
However, when comparing the Bacteroides NanS sequences with that of T. forsythia, the sequence 
alignments were almost identical and the expected conserved sequences were evident in all species 
investigated. Comparing the T. forsythia NanS protein with those seen in Bacteroides a maximum 
sequence identity of 65% was observed. In contrast, other genes involved in sialic acid utilization have 
a higher maximum sequence identity when comparing T. forsythia and Bacteroides, for example 
comparison of NanA proteins shows a maximum identity of 88% between T. forsythia and B. fragilis. 
 
The expected conserved sequences of group II SGNH hydrolases (the family which NanS is predicted to 
belong to) are a GQSN sequence in Block I of the protein and QGEX in Block II (Fig. 6). Interestingly 
there was an exception observed in this alignment, where BT_0447 (a NanS protein of B. 
thetaiotamicron) appeared to align poorly with the other species investigated. On further analysis it 
was seen that this particular NanS contain an extension at the C-terminal (Fig. 7). Analysis of this 
extension was seen to contain a domain of unknown function (DUF187). Using this domain as a Blast 
query against a wide range of bacteria produced significant hits to potential NanS sequences in 
Bacteroides species not previously investigated during the initial studies. Upon further analysis of 
these protein sequences, it was confirmed these also contained the expected conserved sequences as 
well as a predicted signal peptide. 
 
Analysis using public databases indicated the DUF187 domain was present in many bacterial species 
often as part of a protein which also contained a CE4_SF domain (a polysaccharide deacetylase). In 
the Bacteroides species specifically, other than the finding this domain alongside the NanS DUF303 
domain, the DUF187 domain is also part of a protein containing a DOMON_like domain which 
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interacts with sugars in the type 9 carbohydrate binding modules present in a range of glycosyl 
hydrolases. 
 
Another striking observation was the presence of an N-terminal extension observed in most 
Bacteroides species as well as within the T. forsythia NanS protein, which is lacking in the E. coli NanS 
(Fig. 6). A Blast search of this extension shows no conclusive results other then detecting the 
sequence in various Bacteroides NanS. This portion of the protein however is denoted as being part of 
the SGNH hydrolase superfamily but is different to the DUF303 domain associated with the activity of 
NanS. 
 
Considering Bacteroides NanS could potentially be secreted into the lumen of the GI, it was predicted 
that these extensions could be involved in aiding the NanS in adhering to gut cell surface sugars in a 
similar manner to lectin like domain in V. cholera. To test this, alignments of the Bacteroides NanS 
containing this extension and V. cholera lectin like domains were done with no conclusive results. 
However, due to the diversity observed in lectin like domains, it is possible these extensions could 
still be involved in anchoring the enzyme to the surface sugars. 
 
With NanS being the protein of interest, SignalP was used to determine if the various NanS proteins 
contained a predicted signal peptide. In many cases the NanS found within the Bacteroides species 
were found to have a potential signal peptide. Taking this into consideration alongside the 
information previously outlined in regards to Bacteroides catabolism of sialic acid (Stafford et al, 
2011) an alternative pathway is predicted to be present in Bacteroides when compared to that seen 
in E.coli (Fig. 9). 
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Block I 
BACCAC_01087 
 
 
PHRIL----KYTNVLIGEVWLCSGQSNMEFMLRQTITGKKD------IPQAADEQLRLYD 
 
 
338 
BT_0457 DETGF----QYQNVLAGEVWLCSGQSNMEFMLKQASTARAD------IPRAVDQQLRLYD 340 
BACDOR_00666 EKRKL----VYENVLAGEVWLCSGQSNMEFYLNWSATAAQD------VPQAANSNIRFYD 338 
BVU_4140 EKRKL----VYENVLAGEVWLCSGQSNMEFYLNWSATAAQD------VPQAANSNIRFYD 338 
Bache_2780 VGRKL----VYNNILAGEVWLCSGQSNMEFRLNNALTAKAD------IPEAVNENIRLFD 338 
BACCOPRO_02673 GKEKR----TFRHVAVGEVWLCSGQSNMEFLLSQATTGKED------IPQANHPDLRLYN 341 
BACPLE_00585 PQQSH----TFHHVAAGEIWLCSGQSNMQFMLQQTQDGSTA------VSQAYNSQIRLFH 341 
PRABACTJOHN_00552 ASGKL----DYTNVLIGEVWLCSGQSNMAFQVSSAVDSQRKAFL---EFAARKPEIRLFD 339 
PARMER_00328 ESGKL----DYTNILIGEVWLCSGQSNMAFQVSSAVDSQRKAFL---EFAARKPQIRLFD 339 
BDI_2948 PSRTL----NYRDVVAGEVWLCSGQSNMAFRVNESVKEEQQQQL---DYAKQHSQIRLFD 342 
BACSTE_01984 GKQTL----SCKNVLVGEVWLCSGQSNMEFMLKQAATAQTD------IPEANDDKLRLFD 198 
BACINT_02833 KENPI----SIKDILIGDVWLCSGQSNMQWVVNNVTNAEVE------KKNANYPQIRTLN 137 
SIAE1 TLEKINFTLRVHDVLFGDVWLCSGQSNMQMTVLQIFNATRELS-----NTAAYQSVRILS 121 
sIAE2 TLEKINFTLRVHDVLFGDVWLCSGQSNMQMTVLQIFNATRELS-----NTAAYQSVRILS 156 
BT_0447 GEELT-----LKNILIGEVWFCSGQSNMEMPVKGFRGQPVYGSQPYIVSANPKRPLRLYT 148 
Block II 
BACCAC_01087 
 
HPYEPCYLYESGIRPLEQYPVRGVIWYQGESNAHN-CEAHEKLFKLLVGSWRKNWKN--- 
 
514 
BT_0457 HPYEPCYLYESGIRPLEQYPIRGVIWYQGESNAHN-WEAHEKLFKLLVNSWRKNWND--- 516 
BACDOR_00666 HPYEPCYLYESGIRPLEQFPVKGFIWYQGESNAHN-RETHEKLFRLLVESWRKNWGD--- 514 
BVU_4140 HPYEPCYLYESGIRPLEQFPVKGFIWYQGESNAHN-REAHEKLFGLLVESWRKNWGD--- 514 
Bache_2780 HPYEPCYLYEAGIRPLEQFPLKGVIWYQGESNAHN-KDAHGRLFRLLVDSWRRNWDN--- 514 
BACCOPRO_02673 HPYEPCYLYEAGIRTLEQYPIKGVIWYQGESNAHN-MDAHKKLFRLLVESWRRNWQS--- 517 
BACPLE_00585 HPYEPCYLYEAGILPLQQYPLKGIIWYQGESNAHN-MEAHYRLFKLLVNGWRDNWNN--- 517 
PRABACTJOHN_00552 HPYEPCYLYESGIRPLEKFPIRGVIWYQGESNAHN-MEAHERLFHLLTKNWRENWA---- 514 
PARMER_00328 HPYEPCYLYESGIQPLEKFPIRGIIWYQGESNAHN-MEAHEKLFHLLTKNWRENWA---- 514 
BDI_2948 HPYEPCYLFEAGIQPLHRYPIKGIIWYQGESNAHN-MEVHERLFPLLVNSWRQNWN---- 517 
BACSTE_01984 HPYEPCFLFESGILPLSKYPLKGVIWYQGESNTHN-KEAHEKLFKLLIDSWRSNWEQ--- 374 
BACINT_02833 RNDYPSLVYNAMIHPLLSFSIKGVLWYQGENNVGN-AEPYTDWLTCMIGDWRNRWN---- 292 
SIAE1 -PSKHSVLWNAMIHPLCNMTLKGVVWYQGESNINYNTDLYNCTFPALIEDWRETFHRGSQ 274 
sIAE2 -PSKHSVLWNAMIHPLCNMTLKGVVWYQGESNINYNTDLYNCTFPALIEDWRETFHRGSQ 309 
BT_0447 AAGTPTLLWNAMVNPWEGFPVKGVIWYQGEANTPD-PTLYKKLFPAMVSQWRNFFHN--- 291 
 
 
A 
 
 
Block I 
 
 BACDOR_00666 YENVLAGEVWLCSGQSNMEFYLNWSATAAQDVP---QAANSNIRFYDMKARWRTDAVEWD 351 
 BVU_4140 YENVLAGEVWLCSGQSNMEFYLNWSATAAQDVP---QAANSNIRFYDMKARWRTDAVEWD 351 
 PRABACTJOHN_00552 YTNVLIGEVWLCSGQSNMAFQVSSAVDSQRKAFLEFAARKPEIRLFDMKPRWATSAVEWD 352 
 PARMER_00328 YTNILIGEVWLCSGQSNMAFQVSSAVDSQRKAFLEFAARKPQIRLFDMKPRWLTNAVEWD 352 
 BDI_2948 YRDVVAGEVWLCSGQSNMAFRVNESVKEEQQQQLDYAKQHSQIRLFDLKPRWETYAVEWD 355 
 BACCAC_01087 YTNVLIGEVWLCSGQSNMEFMLRQTITGKKDIP---QAADEQLRLYDMKARWRTDAVQWD 351 
 BT_0457 YQNVLAGEVWLCSGQSNMEFMLKQASTARADIP---RAVDQQLRLYDMKARWRTNAVEWE 353 
 BACCOPRO_02673 FRHVAVGEVWLCSGQSNMEFLLSQATTGKEDIP---QANHPDLRLYNMKGNWATDNQAWQ 354 
 BACPLE_00585 FHHVAAGEIWLCSGQSNMQFMLQQTQDGSTAVS---QAYNSQIRLFHMKGKWETNASEWP 354 
 Bache_2780 YNNILAGEVWLCSGQSNMEFRLNNALTAKADIP---EAVNENIRLFDMKGRWATNAVEWD 351 
 BACSTE_01984 CKNVLVGEVWLCSGQSNMEFMLKQAATAQTDIP---EANDDKLRLFDMKARWRTNAVAWN 211 
 BACINT_02833 IKDILIGDVWLCSGQSNMQWVVNNVTNAEVEKK----------NANYPQIRTLNIPRRME 143 
 BT_0447 LKNILIGEVWFCSGQSNMEMPVKGFRGQPVYGS----------QPYIVSANPKRPLRLYT 148 
 Ecoli FNDIIPLTHCPHDVQDMQGYHHPLATNHQTQYG--------------------------- 91 
 Block II 
BACDOR_00666 
 
RPLEQFPVKGFIWYQGESNAHN--RETHEKLFRLLVESWRKNWGDAELPFYFVQLSSIDR 
 
529 
 BVU_4140 RPLEQFPVKGFIWYQGESNAHN--REAHEKLFGLLVESWRKNWGDAELPFYFVQLSSIDR 529 
 PRABACTJOHN_00552 RPLEKFPIRGVIWYQGESNAHN--MEAHERLFHLLTKNWRENW-AEELPFYYVQLSSIDR 529 
 PARMER_00328 QPLEKFPIRGIIWYQGESNAHN--MEAHEKLFHLLTKNWRENW-AEELPFYYVQLSSIDR 529 
 BDI_2948 QPLHRYPIKGIIWYQGESNAHN--MEVHERLFPLLVNSWRQNW-NADLPFYYVQLSSIDR 532 
 BACCAC_01087 RPLEQYPVRGVIWYQGESNAHN--CEAHEKLFKLLVGSWRKNWKNEDLPFYYVQLSSIAR 529 
 BT_0457 RPLEQYPIRGVIWYQGESNAHN--WEAHEKLFKLLVNSWRKNWNDACLPFYYVQLSSLNR 531 
 BACCOPRO_02673 RTLEQYPIKGVIWYQGESNAHN--MDAHKKLFRLLVESWRRNWQSPELPFYFVQLSSLNR 532 
 BACPLE_00585 LPLQQYPLKGIIWYQGESNAHN--MEAHYRLFKLLVNGWRDNWNNPDMPFYFVQLSSLNR 532 
 Bache_2780 RPLEQFPLKGVIWYQGESNAHN--KDAHGRLFRLLVDSWRRNWDNADMPFYFVQLSSIDR 529 
 BACSTE_01984 LPLSKYPLKGVIWYQGESNTHN--KEAHEKLFKLLIDSWRSNWEQPNLPFYYVQLSSIDR 389 
 BACINT_02833 HPLLSFSIKGVLWYQGENNVGN--AEPYTDWLTCMIGDWRNRWN-SELPFYIIQLPNFDS 307 
 BT_0447 NPWEGFPVKGVIWYQGEANTPD--PTLYKKLFPAMVSQWRNFFHNAEMPFYYVQIAPWKS 306 
 Ecoli AKNPQNKFLGACWMQGEFDLMTSDYASHPQHFNHMVEAFRR-----DLKQYHSQLNNITD 219 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 - Sequence allignment comparing E. coli and human NanS with a select few examples of 
Bacteroides NanS proteins. A. Block I and Block II Bacteroides conserved sequences aligned with E. 
coli. B. Block I and Block II Bacteroides conserved sequences aligned with human sialate-O- 
acetylesterase (SIAE). 
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Block I 
 
 
BACCOPRO_02673 GKWEVTLNPLQTGND-YELNISAGKEKRTFRHVAVGEVWLCSGQSNMEFLLSQATTGKED 328 
BACPLE_00585 GKWEVILDPIKAGDN-YELSIQTPQQSHTFHHVAAGEIWLCSGQSNMQFMLQQTQDGSTA 328 
BACDOR_00666 GKWAVDVRPLKAGGP-YTLTVSTEKRKLVYENVLAGEVWLCSGQSNMEFYLNWSATAAQD 325 
BVU_4140 GKWAVDVRPLKAGGP-YTLTVSTEKRKLVYENVLAGEVWLCSGQSNMEFYLNWSATAAQD 325 
BFAG_01068 GDWAITLQPLKAGGP-YTLTVSAGKQKQAFNNVLAGEVWLCSGQSNMEFYLGWSKTAKRD 325 
BT_0457 GKWSVTLPPLKAGGP-YTLKISTDETGFQYQNVLAGEVWLCSGQSNMEFMLKQASTARAD 327 
BDI_2948 GKWTVTLDPLRVSGKSYTLTVSTPSRTLNYRDVVAGEVWLCSGQSNMAFRVNESVKEEQQ 326 
Tannerella GRWTVTLDPMPAQTG-LVLTVATPSRKLTYRQVAVGEVWLCSGQSNMAFRTSEADAAERA 326 
BACINT_02833 GYWEVNLKALETGGP-YQLQIIGKENPISIKDILIGDVWLCSGQSNMQWVVNNVTNAEVE 124 
BT_0447 PFYYVQIAPWKSEGNDKLDWAWFRQCQLELMKEVPGVGMVTTGDAGSELFIHSPYKIKVG 354 
 .                                          .         :  
Block II   
BACCOPRO_02673 KGVIWYQGESNAH-------NMDAHKKLFRLLVESWRRNWQSPELPFYFVQLSSLN---- 531 
BACPLE_00585 KGIIWYQGESNAH-------NMEAHYRLFKLLVNGWRDNWNNPDMPFYFVQLSSLN---- 531 
BACDOR_00666 KGFIWYQGESNAH-------NRETHEKLFRLLVESWRKNWGDAELPFYFVQLSSID---- 528 
BVU_4140 KGFIWYQGESNAH-------NREAHEKLFGLLVESWRKNWGDAELPFYFVQLSSID---- 528 
BFAG_01068 KGIIWYQGESNAH-------NREAHEKLFKLLVESWRKNWENKDLPFYYVQLSSIN---- 528 
BT_0457 RGVIWYQGESNAH-------NWEAHEKLFKLLVNSWRKNWNDACLPFYYVQLSSLN---- 530 
BDI_2948 KGIIWYQGESNAH-------NMEVHERLFPLLVNSWRQNWN-ADLPFYYVQLSSID---- 531 
Tannerella KGVLWYQGESNAH-------NLEAYSKLFPMLINSWRSYWR-ETLPFYFVQLSSLN---- 531 
BACINT_02833 KGVLWYQGENNVG-------NAEPYTDWLTCMIGDWRNRWN-SELPFYIIQLPNFDSINK 310 
BT_0447 KGIIPITEEKHKYGAMINPLNEEYRTHILNVLKEVVTKYPDLDGLMLDRVRYDGITADFS 654 
:*.:    *.:        * :     :  :            : :  ::  .: 
 
 
 
 
Figure 7 - Sialate-O-acetylesterases contain consensus sequences expected of SGNH hydrolases. 
Sequence alignment of a select few Bacteroides species in comparison to T. forsythia shows the 
consensus sequence in both Block I and Block II required for enzymatic activity (boxed residues). 
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Figure 8 - Comparison of the E. coli NanS protein domain to those observed in Bacteroides and 
their presence in other proteins. The various additional domains found in the Bacteroidies NanS 
proteins which are absent in E. coli are found elsewhere in nature. In many cases these domains are 
associated with other domains involved in carbohydrate utilization. GAT-1 is a type 1 
glutamineamidotransferase, CES4_SF belongs to the carbohydrate esterase family 4, DOMON_like 
domain is a ligand binding domain which interacts with sugars and hemes, FN3 (fibronectin type 3 
domain) is found in many bacterial hydrolases. Not to scale. 
42 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 – A general sialic acid catabolism pathway in Bacteroides. In Bacteroides a novel NanE has 
been identified which does not require ManNAc-6-P as a substrate. Instead the NanE directly acts on 
the ManNAc to produce GlcNAc which is then phosphorylated to GlcNAc-6-P by RokA (Brigham et al, 
2009). In addition to this Bacteroides is also predicted to contain a secreted sialidase and esterase 
involved in scavenging of sialic acids. 
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Discovery of novel sialic acid utilization genes in the Bacteroides 
 
 
As mentioned previously, sialic acid can be modified with various other groups aside from acetylation 
(Shauer, 2004). In a similar manner to acetylation of Neu5Ac causing a decrease in NanH activity, it is 
likely that addition of various other groups can also hinder sialidase activity. If this is the case it would 
be logical for Neu5Ac utilizing bacteria to have a way to overcome this. The presence 
of genes encoding potential enzymes involved in priming Neu5Ac for NanH function was observed in 
 
certain nan gene clusters in Bacteroides (Fig. 4). These genes could be of significant importance 
given the diversity of sialic acid and the presence and positioning of these genes in the Bacteroides 
nan clusters. 
 
As indicated in figure 4, P. merdae appears to have arylsulphatase situated upstream of the sialidase. 
Interestingly homologues of the arylsulphatase were observed mainly in Sphingobacterium, 
Blastopirellula, Rhodopirellula and Pedobacter. Although direct homologues were rarely seen in 
Bacteroides, the species with the maximum sequence identity belonged to the Bacteroidetes phylum 
(the phylum to which Bacteroides belongs). In addition to the presence of this sulphatase within the 
sialic acid catabolism cluster, only one other Bacteroides (of those investigated) was seen to have a 
sulphatase within the cluster. Given that sialic acid can be modified by the addition of a sulphate 
group, the presence of a sulphatase would increase the sialic acid utilization potential of these 
Bacteroides. 
 
A Ser/Thr phosphatase was observed adjacent to one of the potential NanS enzymes of B. 
thetaiotamicron. This protein was indicated to be part of the Calcineurin-like phosphoesterase family. 
Upon further analysis, homologues of this protein was observed in many different Bacteroides species 
but not seen within any other sialic acid nan operon in the species investigated. Homologues of this 
protein were also seen in many Prevotella and Tannerella species, both of which utilise sialic acid as a 
nutrient source. The presence of a phosphatase with sialic acid specificity 
would give these bacteria a competitive edge within their environment. 
 
 
Cloning of nanS candidates from B. thetaiotamicron 
 
 
Genomic analysis has indicated that homologues of the E. coli NanS enzymes are ubiquitous in 
bacteria of the Bacteroides genus. The most well studied commensal in the Bacteroides genus is B. 
thetaiotamicron, it is also one of the most dominant Bacteroides species in the gut accounting for 
6% of all bacteria and 12% of all Bacteroides (Eckburg et al, 2005). Using amino acid sequences for 
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gene products involved in sialic acid catabolism from E. coli, Tannerella forsythia and B. fragilis as Blast 
queries, a gene map of potential B. thetaiotamicron sialic acid operon was constructed (Fig. 5). This 
analysis indicated the presence of two potential nanS genes within the same cluster. 
 
Analysing the amino acid sequences of these putative NanS proteins showed only one of the two to 
contain a strong potential signal peptide (BT_0457). Both BT_0447and BT_0457 are longer in length 
in comparison to the E.coli NanS. BT_0457 not only has a signal peptide but also contains an N- 
terminal extension while the other (BT_0447) appears to have a C-terminal extension of 
approximately 200 amino acids (Fig. 7). 
 
These finding formed the basis for the initial experiments. The aim was to successfully clone both 
genes into two vectors; the pBADcLIC vector which tags the C-terminal of the protein with decahistidin 
and the pETYSBLIC-3C which tags the N-terminal with hexahistidine. Cloning into the pETYSBLIC-3C 
vector requires the removal of the signal peptide (if one is predicted to be present) for cytoplasmic 
expression. 
 
First we designed primers for cloning of the entire gene length and LIC cassette for both genes into 
the two above described vectors. These were then used to amplify the genes from genomic DNA 
using a KOD polymerase PCR reaction at a 55°C annealing temperature. The PCR products were 
purified and genes of interest were introduced to the expression vectors, followed by 
transformation initially into E. coli supercompetent cells (as described in Material and Methods). 
 
Colonies present following transformations were screened using whole cell PCR for the uptake of the 
correct plasmid. The presence of the recombinant plasmid was determined by the appearance of 
bands corresponding to the expected size of the BT_0447 and BT_0457 inserts. The plasmids from the 
colonies shown to potentially contain the recombinant plasmids were purified and correct orientation 
and position of insert was established using the appropriate restriction enzyme digests (Fig. 8 and 
Table 2). It is important to note that although all the appropriate band were seen faintly during early 
stages of migration during electropherisis analysis of the restriction enzyme digests, the bands are not 
visible during later stages of migration due to the poor staining of the cybersafe staining that was used 
during the initial stages of the study. 
 
Using whole cell PCR and restriction enzyme digest it was concluded that the pBAD-BT0457 and 
pBAD-BT0447 constructs were as expected. Confirmation of recombinant plasmids was achieved 
through sequencing before the plasmids were transformed into the appropriate expression E. coli 
strains (as described in Material and Methods). 
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Figure 10 – Restriction enzyme digests of pBAD-BT0457 and pBAD-BT0447. Two double restriction 
enzyme digests were carried out on each of the recombinant plasmids. The XbaI and BseRI digest of 
pBAD-BT0457 was expected to produce bands of sizes 5514bp and 704bp. Although observed each 
time the digests were repeated, the smaller band (at approximately 700bp) was difficult to visualise 
due to poor staining. BglII and HindIII digest of pBAD-BT0457 was expected to produce bands of sizes 
1297bp and 4921bp. BseRI and SacII digest of pBAD-BT0447 was expected to produce bands of sizes 
 
2282bp and 4512bp. In this case a third band is also present which correlates to the size expected of 
an undigested plasmid. XbaI and AfeI digest of pBAD-BT0457 was expected to produce bands of sizes 
1239bp and 5555bp.
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B. thetaiotamicron candidate sialate-O-acetylesterases can be successfully expressed in E. coli 
but are insoluble 
 
 
Once the recombinant plasmids were successfully transformed into the expression strains of E. coli, 
protein expression was attempted. Optimal expression was determined through bacterial growth at 
37°C, 30°C and 21°C with growth measured hourly over a three hour period. To achieve this cells 
were grown in LB to mid log phase and expression induced with either arabinose (pBAD vector 
constructs) or IPTG (pET vector constructs). Cell samples taken hourly were then tested for protein 
expression through SDS-PAGE analysis (as described in Material and Methods). 
 
Analysis of Coomassie-stained SDS-PAGE gels indicated that both BT_0457 (78.62 Kda) and BT_0447 
(101.38 Kda) accumulated to higher levels after growth at 30°C compared to 21°C when expressed in 
either the pBAD or the pET vectors. There is a clear band in each case at the expected band size with 
increased expression at every hour for three hours following induction (Fig. 10 & 11). To maximise 
protein expression, solubility tests were carried out at both temperatures for all constructs (Fig. 12 & 
13 ). Analysing these tests indicated only BT_0457 expressed from the pBAD vector appeared to be 
soluble when expressed at 21°C (Fig. 12). 
 
The pBAD-BT0457 construct was then expressed (at 30°C) and purified using nickel affinity 
chromatography as described in Material and Methods (Fig. 13). Following gel analysis elution 
fraction 2, containing a band corresponding to the expected size of the BT_0457 protein, was gel 
extracted and the protein identified through digestion with trypsin by the proteomics lab at the 
University of York Technology Facility. Unfortunately, the excised protein in this case was not as 
expected and instead was identified as a KatE enzyme. 
 
Due to the difficulties faced in obtaining soluble proteins of interest using the vectors described 
above an alternative approach was taken in an attempt to increase protein solubility. 
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Figure 11 - Expression of pBAD-BT0447 and pBAD-BT0457 at varying temperatures. Protein 
expression was tested 21 °C and 30 °C over three hours post induction (PI) and after 24 hours. 
BT1 is protein BT_0457 and BT2 is protein BT_0447. Protein of interest is indicated by an arrow. 
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Figure 12 - Expression of pET-BT0447 and pET-BT0457 at varying temperatures. Protein 
expression was tested 21 °C and 30 °C over three hours post induction (PI) and after 24 hours. 
BT1 is protein BT_0457 and BT2 is protein BT_0447. Protein of interest is indicated by an arrow. 
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Figure 13 - Protein solubility of proteins expressed in pBAD vectors under various conditions. 
Protein solubility was tested with Tris and a phosphate buffer at 21 °C and 30 °C. BT1 is protein 
BT_0457 and BT2 is protein BT_0447. 
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Figure 14 - Protein solubility of proteins expressed in pET vectors under various conditions. Protein 
solubility was tested with Tris and a phosphate buffer at 21 °C and 30 °C. BT1 is protein BT_0457 
and BT2 is protein BT_0447. 
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Figure 15 - Purification of pBAD-BT0457. Following large scale expression, cells were lysed in 
phosphate buffer. The resultant lysate was purified using nickel affinity chromatography and each 
fraction analysed on a 12% acrylamide gel. A band corresponding to the expected protein size was 
seen in the second elution (as indicated by the arrow). 
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Identification of additional putative acetyl esterases in B. thetaiotamicron 
 
 
During the initial analysis of the Bacteroides NanS proteins, it was established that the well 
characterized bacterial NanS (from E. coli) has limited sequence similarity with those seen in 
Bacteroides (Fig. 6A). Aligning the Bacteroides NanS proteins with various mammalian sialate-O- 
acetylesterases, however, showed greater similarity at 44% maximum sequence identity when 
comparing the B. thetaiotamicron NanS with the SIAE protein in humans (Fig. 6B). Although still low 
this maximum sequence identity is higher than that observed when Bacteroides NanS is compared to 
the E. coli NanS where a maximum sequence identity of 34%, for the highest BLAST search result, 
was observed. 
 
 
Mammalian sialate-O-acetylesterases are found in two forms – cytosolic and lysosomal – both of 
which are coded by the same gene and expressed differently in various tissues (Takematsu et al, 
1999). Although conserved residues and enzymatic residues have been identified, very little is 
 
known about the structure of the protein (Zhu et al, 2003). Upon further analysis using Pfam, it was 
found that the only domain annotated to be present in the human sialate 9-O-acetylesterase (SIAE) 
was a domain of unknown function (DUF303) which almost spanned the entire length of the protein. 
This domain was also observed in various Bacteroides candidate NanS enzymes. 
 
A deeper analysis of the DUF303 domain within Bacteroides identified its presence in 204 protein 
sequences from 45 species of Bacteroides (Fig. 17). These were designated by Pfam as either sialic 
acid 9-O-acetylesterase, acetyl xylan esterase or as uncharacterized proteins. Looking specifically at 
the B. thetaiotamicron genome, there are likely 10 proteins that contain the DUF303 domain. These 
not only aligned well with each other but also showed significant sequence similarity with other 
NanS proteins in various other Bacteroides species. 
 
It was decided a single representative would be taken from each of the major clades observed when 
 
a tree of the proteins containing the DUF303 domain was constructed (Fig. 16). In addition to cloning 
the full length protein for all the chosen proteins, in the case of BT_0447 and BT_0457, each 
different domain was also decided to be cloned and expressed individually. 
 
 
 
Use of a range of protein fusion partners to increase solubility of recombinant sialate O- 
acetylesterases 
 
 
Due to poor solubility of recombinant esterases using simple expression systems, we chose to 
investigate the solubility using In-Fusion cloning. This utilised a modified set of pET-based plasmids 
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that have been engineered in the Protein production lab of the York Technology Facilty (TF) by Dr 
Jared Cartwright. This allowed the same amplified PCR product to be ligated into one of 4 similar 
vectors that create genetic fusions to Maltose Binding Protein (MBP), Glutathion S-transferase (SGT), 
Immunity protein 9 (Im9) and Green Fluorescent Protein (GFP). 
 
Achieving In-Fusion cloning involved designing primers which not only amplified the gene of interest 
during the PCR process, but also incorporated vector complimentary regions flanking the gene in the 
final PCR product. The vectors were treated with BseR1 to produce these overhangs for which the 
adaptors on the PCR products are complementary. During the In-Fusion ligation independent cloning 
process, the In-Fusion enzyme then anneals the complementary sequences and so inserts the gene 
of interest at a specific position within the vector (as described in Material and Methods). 
 
 
Each target, amplified from genomic DNA using high fidelity PCR, was treated with Dpn1 and PCR 
cleaned up using a mini-prep kit. PCR products were then cloned into the four vectors and 
transformed into XLI-blue supercompetant E. coli cells. Insert presence was determined through 
restriction enzyme digests of purified plasmids from colonies present following the transformation. 
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Figure 16 - The DUF303 domain is found across many species of the Bacteroides. Out of the 11 
proteins identified in B. thetaiotamicron (grey and colored blocks) 5 targets were chosen for 
characterization (colored blocks). Each of the targets was chosen as a representative of the various 
clades observed.
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 Putative acetylesterases were successfully expressed using the Infusion cloning 
 
 
Following PCR amplification of the selected targets electrophoresis was used to determine correct 
product size (Fig. 17A). The PCR products were extracted and purified to ensure maximum efficiency 
during the plasmid construction process. Following successful plasmid construction as determined 
by plasmid restriction enzyme digests (Fig. 17B); plasmids were purified and transformed into XL1- 
blue supercompetent cells. Successful transformations were used to purify recombinant plasmids, 
which were introduced to BL21 (DE3) E. coli cells for overexpression of proteins. Following growth 
and protein expression induction, cells were harvested and the lysate analysed using SDS PAGE (as 
described in Material and Methods). Figure 18 shows an example of the results obtained during this 
process. Using this method a series of 40 plasmid constructs were created to express the 10 targets 
with their various fusion partners (Table 3). 
 
Once we had observed evidence for recombinant protein synthesis (Fig. 18), we tested protein 
solubility (Fig. 19). Initially the cells were lysed using Bugbuster with the addition of a phosphate 
buffer (Fig. 20A). Using this method resulted in partial solubility or insolubility of the proteins. This 
lead to the possibility of salts within the phosphate buffer interfering with the solubility and so the 
samples were re-tested following lysis with Bugbuster alone (Fig. 20B). As shown the removal of the 
phosphate buffer appeared to make no difference in the solubility. 
 
Due to limited success of solubility using Bugbuster as a lysis method, various other methods were 
investigated to determine if solubility could be increased. A basic lysis buffer was made to include 
lysozyme, DNAse and a detergent (Fig. 21 and Fig. 22) which solubilised proteins that were previously 
insoluble. Sonication and a different version of Bugbuster (HT protein extraction reagent) was also 
tested (data not shown) and it was determined for large culture lysis the detergent based lysis buffer 
would be used. 
 
Using this method a total of 5 proteins were expressed in large cell cultures before the cells were lysed 
and the clear supernatant containing the soluble proteins was purified. Purification was carried out 
using nickel column affinity and analysed using SDS PAGE (Fig. 23 and Fig. 24). Elutions 
containing the protein of interests were dialysed into Tris buffer and stored for enzymatic analysis. 
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Figure 17 - PCR amplification and restriction enzyme digests.PCR (A) and restriction enzyme digests 
 
(B) ensured successful plasmid construction. Refer to Table 3 for abbreviations of gene names. 
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Figure 18 - Protein expression was determined using SDS-PAGE. Samples taken previous to 
induction with IPTG and post induction with IPTG were analyzed for correct expression. As predicted 
samples post induction had increased levels of protein expression in comparison to pre induction. 
Refer to Table 3 for name abbreviations and expected protein sizes. 
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Figure 19 - Protein solubility was determined using SDS-PAGE analysis. Samples taken after 3 hours 
post induction were lysed using Bugbuster in the presence of a phosphate buffer. Using this method 
of lysis only a small sample of proteins tested was found to be soluble. Refer to Table 3 for name 
abbreviations and expected protein sizes. 
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Figure 20 - Protein solubility was unaffected by the addition of a phosphate buffer. Samples 3 hour 
after induction were solubilised using Bugbuster in the presence of a phosphate buffer (A) and 
absence of a phosphate buffer (B). The removal of the phosphate buffer made no difference in the 
solubility of the proteins. Refer to Table 3 for name abbreviations and expected protein sizes. 
 6
0
 
 
 
 
 
 
 
 
 
Table 3 - Table of final protein constructs. Each of the individual proteins was cloned into four of expression vectors to include fusion partners. The left of the table 
shows the various protein domains that were expressed. (Colours match those in figure 14). The right side of the table shows the expected protein sizes with the 
addition of the fusion partners. 
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Figure 21 - Protein solubility improved when cells were lysed using a detergent based lysis buffer. 
Samples 3 hour after induction were solubilised using detergent based lysis buffer which produced 
partial (BT1full-MBP) or complete (BT6-Im9) protein solubility. Refer to Table 3 for name 
abbreviations and expected protein sizes. 
62  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22 - Improved protein solubility was dependent on the presence of detergent in the lysis 
buffer. Following analysis of the lysis buffer it is evident that solubility of the proteins is unaffected 
by the presence of DNAse or Lysozyme and is reliant on the detergent Triton X100. This is 
exemplified by diminished protein solubility in the absence of Triton X100. Cell lysis using sonication 
also appears to make no significant difference in the amount of soluble protein when compared to 
lysis buffer usage. T is total lysate and S is soluble lysate. 
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Figure 23 - Purification of proteins 
using Ni-affinity chromatography. 
Example of SDS-PAGE gels 
following purification. Presence of 
protein is clearly visible in various 
elations for BT1-MBP (A) and 
BT1ext-MBP (B). Refer to Table 3 
for name abbreviations and 
expected protein sizes. 
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Figure 24 - Purification of five proteins. Each of the proteins that was successfully expressed and 
found to be soluble was purified using Ni-column affinity. Elations from this process containing the 
most protein were then used to determine concentration using a nano-drop. Proteins were also 
analyzed on an SDS-PAGE gel prior to enzyme assays. Refer to Table 3 for name abbreviations and 
expected protein sizes. 
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An enzyme based assay using an acetylated substrate showed each of the purified proteins to 
have enzymatic activity 
 
 
Determining enzymatic activity of the purified enzyme was achieved using an enzyme assay based on 
p-Nitrophenyl Acetate (pNPA). An increase in OD of the samples incubated with the PNPA correlates 
to de-acetylation of the PNPA by the enzyme. This is also visibly evident by the change in colour from 
clear to yellow of the test sample. Following incubation at 40°C of the purified enzyme, OD405 
readings were taken every five minutes for a minimum of 30 minutes. In addition to testing enzyme 
activity of purified enzymes of interest, a xylan esterase at various dilutions was tested on the PNPA 
substrate. 
 
In the control experiment it is evident that at higher concentrations of enzymes the acetyl group from 
the PNPA is removed faster by the esterase enzyme in comparison to enzymes at lower 
concentrations (Fig. 25). It is also evident that pre-incubation of the enzyme at 40°C for 10 minutes 
before addition of the pNPA substrate seemed to cause no significant difference in the rate at which 
the conversion occurred. In both cases maximum acetyl release was achieved at 5 minutes indicated 
by a consistent OD405 reading of approximately 0.3 between 5 and 15 minutes. When the 
concentration of the substrate is doubled the OD405 readings of the reaction also doubles, despite the 
enzyme concentration remaining the same. Interestingly when the pNPA concentration was doubled 
the rate of the conversion appeared to remain constant, with the OD405 reaching approximately 0.6 at 
5 minutes and changing very little over the next 10 minutes. 
 
Each of the purified proteins were also tested against the pNPA substrate to determine their 
enzymatic activity (Fig. 26). Controls samples using 1 unit of the xylan esterase and 10 units of the 
xylan esterase were also run in parallel to the assays carried out using the purified proteins. 
Unexpectedly there appears to be no increase in OD405 readings when the enzyme is present 10 fold. 
There does appear to be a small decrease in the OD405 reading when 10 units of the control enzyme 
was present in the sample in comparison to the 1 unit sample. 
 
It is evident from the results obtained that each protein was able to convert the pNPA to pNP, but at 
different rates. In each case the maximum enzymatic activity was reached within 5 minutes with 
little change in OD405 after this time. In the case of BT_0457 full length protein this maximum was 
reached within 30 seconds of pNPA addition, following a similar trend observed in the control xylan 
esterases. 
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Although each of the proteins appeared to have enzymatic activity, each enzyme has a different end 
point despite each sample containing the same PNPA and enzyme concentration. Of particular 
interest is the enzyme activity observed during the assay using only the purified extension domains of 
BT_0457 and BT_0447. This result was unexpected as the various domains were not the DUF303 
domain expected to have acetylesterase activity. The BT_0457 extension has double the enzymatic 
activity when compared to the full length BT_0457 protein. The BT_0447 extension has even greater 
enzymatic activity reaching a maximum OD405 of approximately 0.7. However the initial rate of 
conversion appears to be almost identical to that observed in the presence of the BT_0457 
extension domain, where both proteins reached an approximate OD405 of 0.55 within 30 seconds of 
pNPA addition. 
 
The full length BT_0457 protein has the most similar enzyme activity to the 1U of the control xylan 
esterase. In contrast, BT_4180 has the slowest rate of enzyme activity and appears not to reach 
above OD405 0.1 even after an hour of incubation at 40 °C. This is particularly surprising given that 
this protein has been described as a xylan esterase. Out of the purified enzymes, BT_0985 appears to 
 
have the greatest enzymatic activity, reaching a maximum OD405 of approximately 0.85. This is 
interesting given that this putative sialate-O-acetylesterase is the closest homologue found in B. 
thetaiotamicron to the SIAE found in humans. Although reaching the same OD405 as the BT_0447 
extension domain within the first 5 minutes, the OD405 of BT_0985 continues to rise whereas that of 
BT_0447 extension plateaus. 
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Figure 25 - Enzymatic activity of Xylan esterase. The activity of Xylan esterase (XE) against pNPA was 
tested at various XE concentrations. Decreasing concentration of XE showed a decrease in enzymatic 
activity (as determined by a change in OD0405) against the pNPA substrate. Error bars represent 
standard deviation of triplicate measurements. 
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Figure 26 - Enzyme activity of purified proteins. Each of the purified proteins was tested for 
enzymatic activity against 0.5 mM of pNPA substrate. A change in OD405 was used to determine the 
enzymatic activity of 0.5 μM of enzyme. There is clear evidence of enzymatic activity against the 
substrate in all cases. Refer to Table 3 for name abbreviations and expected protein sizes. Error bars 
represent standard deviation of triplicate measurements. 
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Discussion 
 
The human intestine is host to approximately 100 trillion microbial cells. This is tenfold higher than the 
number of human cells (Ley et al, 2006; Karlsson et al, 2010). These microbial cells make up what is 
known as the microbiota and not only do they impact human health, but have also been linked 
with inflammatory bowel disease and obesity (Ley et al, 2005; Manichanh et al, 2006; Qin et al, 
 
2010; Tumbaugh et al, 2009). The microbiota in the human colon is composed of two main phyla of 
bacteria; Bacteroidetes and firmicutes. Together they make up a total of 95 – 99% of the gut bacteria 
with the relative abundance ranging from between 17 – 60% for Bacteroidetes and 35 – 80% for 
Firmicutes (Costello et al, 2009; Eckburg et al, 2005; Tap et al, 2009). It is an increase in the relative 
abundance of firmicutes to Bacteroides that has been linked with the obesity in both mice and 
humans (Tumbaugh et al, 2009; Tumbaugh et al, 2003). 
 
The Bacteroides are the most abundant of the Bacteroidites phylum and make up the core 
component of the gastrointestinal tract (GI tract) microbiota (Costello et al, 2009; Eckburg et al, 
2005; Tap et al, 2009). This microbiota complements the host enzymes within the gut with the activity 
of their own enzymes. The main function of these is the degradation of polysaccharides and the 
production of vitamins (Karlsson et al, 2010). Members of the Bacteroides have adapted to the 
surviving in the mammalian gut where there is a large abundance of undigested polysaccharides that 
the human enzymes are unable to digest. 
 
The perfect example of such an adaptation is observed in B. thetaiotamicron. B. thetaiotamicron 
was the first species of Bacteroides to have its complete genome sequenced. This sequencing 
revealed the presence of 172 glycoside hydrolyses and 162 homolgues of the SusD and SusC outer 
membrane polysaccharide binding proteins for the utilization of polysaccharides (Xu et al, 2003). 
This repertoire of enzymes involved in acquisition and metabolism of polysaccharides makes B. 
thetaiotamicron an exemplary glycophile which is able to break down a large range of dietary 
polysaccharides (Sonnenburg et al, 2005; Xu and Gordon, 2003). Over half of the carbohydrate 
degrading enzymes are predicted to be secreted into the periplasmic or extracellular space leading 
to the release of oligo- and monosaccharides from the host mucus and dietary polysaccharides for 
the consumption by B. thetaiotamicron or other members of the microbiota (Sonnenburg et al, 
2005). 
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The analysis indicated that although B. thetaiotamicron contained many of the genes required for 
sialic acid catabolism, it was missing two genes essential for the transport of sialic acid through the 
inner membrane let alone its catabolism (Fig. 5, 27). During this study it was also established that B. 
thetaiotamicron has a large range of potential sialate-O-acetylesterases. 
 
Lateral gene transfer is a strong force of bacterial evolution. It has been suggested that the lateral 
gene transfer has played a major role in the evolution of bacteria in the human intestine (Doolittle, 
1999; Xu et al, 2007). This could potentially explain the sequence similarity observed between the 
 
human sialate acetylesterase and those observed in B. thetaiotamicron. A good example of 
horizontal gene transfer is in fact observed in genes involved in sialic acid catabolism. The nanA 
genes from Bacteroides have been shown to branch closely to members of the Eukarya kingdom, 
providing evidence for the horizontal gene transfer between Bacteroides and eukaryotes (Almegro- 
Moreono and Boyd, 2009; De Koning et al, 2000). 
 
Given that this bacterium is unable to catabolise sialic acid it is surprising that there is such a large 
repertoire of genes involved in the scavenging of sialic acid. Recently Vimr described B. 
thetaiotamicron as a “spitter” in the gut microbiota in regards to sialic acid. This fitting name describes 
the activity of B. thetaiotamicron, which cleaves the terminal sialic acid of glycoconjugates but allows 
the released sugar to enter the extracellular milieu (Vimr, 2013). While the sialic acid is 
not used by B. thetaiotamicron, it is the subterminal sugars that are hydrolysed by specific 
glycosidases, transported into the cell and used for growth. The sialic acid would then be utilized by 
other bacteria within the gut which lack the enzymes required for the release of sialic acid from 
glycoconjugates, such as E. coli (Vimr, 2013). 
 
In addition to this explanation, it has been postulated that the ability of B. thetaiotamicron to cleave 
sialic acid from various structures within the human gut could confer to protection of the human host 
from viral infection. This was demonstrated by Varyukhina and colegues, who showed that the extent 
of rotavirus infection inversely correlated to the ability of bacteria to produce soluble factors (such as 
sialidases) that are able to specifically modify cell surface glycan structure. Their results demonstrated 
that the manipulation of cell surface glycan composition by B. 
thetaiotamicron was able to alter the infection of human intestinal cells by the rotavirus. Although 
 
in this study they specifically investigated the effect of an increase in galactose density caused by the 
action of B. thetaiotamicron enzymes, it was indicated that in addition to this increase, a decrease 
in sialic acid, mannose and fucose density correlated to a reduction in viral infection (Varyukhina et 
 
al, 2012). There is the possibility that this decreased is observed because a release of sialic acid 
hinders the attachment of the virus but this hypothesis is of yet to be explored. 
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Figure 27 – Predicted sialic acid catabolism pathway in B. thetaiotamicron. Various aspects of the 
predicted Bacteroides sialic acid catabolism pathway appear to be missing in B. thetaiotamicron as 
indicated by red crosses. 
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Although the release of sialic acid for the use by other gut bacteria rationalizes the inability of B. 
thetaiotamicron to grow on sialic acid, it does not explain the presence of the multiple putative 
acetylesterases scattered across the genome of the bacterium. Although those investigated in this 
study were shown to have esterase activity their substrate specificity has as of yet not been 
identified. It is entirely possible that each putative enzyme removed the acetyl group from different 
positions on the sialic acid to allow maximum activity of the NanH sialidase. Given that B. 
thetaiotamicron forges the mucosal surfaces in search of energy sources it is able to utilize it would 
make sense to maximize its potential by ensuring that a series of enzymes are present with varying 
substrate specificity to release the multitude of sialic acid modification seen in the gut. This would 
then allow the bacterium to reach a wider range of potential energy sources. During previous genetic 
analysis, B. thetaiotamicron has been described as a “genetic pack rat” due to the presence of 
multiple genes appearing to be involved in the same processes (Wexler et al, 2007). 
 
Before the candidate sialate-O-acetylesterases of B. thetaiotamicron could be analysed for the 
enzymatic activity the insolubility of the proteins needed to be resolved. This was achieved partly 
through the construction of protein fusions and partially by adjusting the method of cell lysis from 
using Bugbuster to using a detergent based lysis buffer. When proteins were expression in standard 
vectors, each protein was insoluble. Initially we thought this was due to the large sizes of the 
expressed proteins and so during the alternative cloning process individual domains were also 
expressed. When, however, the majority of the expressed fusion proteins still remained insoluble until 
the lysis method was altered it indicated the possibility that using a detergent based lysis buffer might 
have increased the solubility of the originally expressed proteins. 
 
When using Bugbuster to lyse the cells we had very limited success in protein solubility. Only 3 of the 
 
40 expressed proteins were partially soluble while the rest remained insoluble. Interestingly those 
that were soluble were the individually expressed extensions of BT0447 and BT0457. This could 
possibly be due to Bugbuster interacting with the DUF303 domain found in the other proteins and 
preventing their solubility. In addition to this each of the soluble proteins had different fusion 
partners indicating that the presence of a specific fusion partner does not necessarily correlate to 
increased protein solubility. 
 
The enzyme assay carried out during this study indicated that each of the purified proteins had 
enzymatic activity. Although the basic assay was able to determine this, it was unable to determine 
the substrate specificity of each of the putative acetylesterases. This is of particular interest given 
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that B. thetaiotamicron appears to have many such enzymes. It has previously been shown that 
sialate-O-acetylesterases from different species have various substrate specificities. It would be 
interesting to see if the two NanS proteins within the sialic acid utilization cluster have a stronger 
substrate specificity to sialate-9-O-acetylesterase given that Neu5,9Ac2 is the most common di- 
acetylated for of sialic acid found in the human GI tract (Schauer, 2004). 
 
The most surprising result obtained during the enzyme assay was the enzymatic activity of the 
purified extension domains. The possibility of errors in the process of the enzyme activity was 
eliminated during the control experiment using a brought xylan esterase against the substrate at 
various concentrations. This control ensured that the conversion of the pNPA to pNP was indeed 
enzyme dependent. It was also established that there was no detectable spontaneous release of the 
acetyl group in the absence of an enzyme during the time period of the assay. However, further 
experimental analysis is required to confirm these unusual findings. 
 
Although it is predicted that the DUF303 domain observed within each of these proteins is the 
catalytic portion of the protein (due to its presence in known characterized sialate-O-acetylesterase) 
the N-terminal extension found in BT_0457 contains an SGNH hydrolase domain. In a similar manner 
the DUF187 extension domain of the BT_0447 protein is predicted to be related to putative glycosyl 
hydrolases. In both cases these domains have the potential to work as acetylesterases. This would 
be a surprising result indicating that these two proteins have two domains which are both involved 
in deacetylation, although it is possible each domain has different substrate specificity. Until the 
DUF303 domain of these proteins is expressed in the absence of the extensions and the enzyme 
activity tested, the possibility remains that the DUF303 domains of BT_0457 and BT_0447 are 
inactive. 
 
It was interesting to see that during the enzyme assay each of the proteins investigated appeared to 
have different end point despite the concentration of added substrate remaining the same. Although 
maximum conversion was reached within 5 minutes in each case, this maximum was different for each 
enzyme. A potential explanation for this is the presence of an inhibition loop. This would rely 
on the released acetate binding the enzyme directly, causing a change in the enzyme and so 
preventing its enzymatic activity. 
 
Another interesting observation was the higher enzymatic activity seen when the substrate was 
incubated in the presence of the extension in BT_0457 in comparison to that seen during incubation 
with the full length protein. A potential explanation for this would be that the extension domain has a 
higher affinity and so a higher enzymatic activity in comparison to the full length protein. Given 
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that each of the samples were normalised to contain the same concentration of total enzyme, the 
presence of the extension in the full length protein would be diluted in comparison to the 
concentration when the extension was expressed alone. Although unlikely, it is however, impossible 
to rule out the possibility that the extension domain somehow hinders the activity of the DUF303 
domain without performing the enzyme assay using the DUF303 domain alone. 
 
Another explanation for this increase in activity would rely on the presence of the potential inhibition 
loop described above. The binding site for the release acetate could potentially found in a part of the 
protein that is not present in the specific domain expressed from as the BT_0457 extension. The 
binding site would however be present in the full length protein potentially explaining the different 
maximum activities observed between the two. Given that the BT_0447 extension also appears to 
have a higher enzymatic activity in comparison to the BT_0457 full length protein, it would be 
interesting to see if the full length BT_0447 protein also has a lower enzymatic activity compared to 
its stand alone extension domain. 
 
There is the possibility of incorrect cloning, despite PCR and restriction enzyme digest analysis 
indicating the correct genes were present in the recombinant plasmids. Confirming without a doubt 
that the purified proteins were in fact as expected would require plasmid sequencing as only partial 
sequencing evidence is currently available. In addition to this, to eliminate any potential errors during 
the construct preparations, the proteins require sequencing through peptide mass spectrometry. 
 
During the genetic analysis of various Bacteroides species, the presence of putative sulphatases and 
phosphatases within the nan operons was unexpected but it is entirely logical for these species to 
contain these enzymes. Previous mass spectrometry of human mucin oligosaccharides isolated from 
the ileum, cecum, transverse colon and rectum showed that the human mucin oligosaccharides 
contains 46 neutral carbohydrate chains and 50 acidic carbohydrate chains (Robbe et al, 2004; Vimr, 
2013). The neutral residues did not contain Nue5Ac or sulphate residues. The acid chains, on the 
other hand, included Neu5Ac, sulphate or sulphated Neu5Ac (Vimr, 2013). It was initially postulated in 
1993 that some mucosal bacteria have glycosulphatases in addition to the acetylesterases and 
sialidases needed for growth on Neu5Ac (Corfield et al, 1993). This supports the idea that bacteria 
containing a putative sulphatase would be able to prime the Neu5Ac for release via the sialidase in a 
similar manner to that expected of NanS for utilization as a growth substrate or release to reach 
subterminal sugars on within mucin oligosaccharides. 
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In the Bacteroides species investigated during this study a single putative phosphatase was identified 
to be present within the sialic acid catabolism clusters. Modification of sialic acid with a phosphate 
group is found at residue O-9 (Schauer, 2004). The putative phosphatase was seen in B. 
thetaiotamicron and for the reasons discussed above about the role of this bacterium as a forger, the 
presence of an additional enzyme aiding its ability to release sialic acid would give provide a 
competitive advantage. However, Neu5Ac9P as of yet has only been found as a free cytosolic form 
which is present as an intermediate of sialic acid biosynthesis (Schauer, 2000). If this is the only version 
of a phosphated sialic acid, the presence of the sulphatase within the sialic acid catabolism cluster of 
B. thetaiotamicron is a mystery given its ability to utilize free sialic acid as a growth factor. 
 
According to public databases, this phosphatase contain a metalophosphoesterase domain which is 
found in the range of phosphoesterases including phosphoserine phosphatases and sphingomyelin 
phosphoesterases. This domain is found 846 times in Bacteroides and 15 times within B. 
thetaiotamicron. 
 
In addition to a phosphatase, two predicted sulphatases were also observed in two individual 
Bacteroides species within the sialic acid catabolism clusters. One was seen in B. fluxus and the other 
in P. merdae. The public databases indicated that both observed sulphatases belonged to the same 
family. Interestingly this family also includes sulphatases which hydrolyse the release of sulphate 
groups from Neu5Gc (Arylsulphatase B) but none have been described which are specific for 
Neu5Ac. Within Bacteroides proteins of this family are seen 1458 times with 31 within B. 
thetaiotamicron alone. In nature the addition of a sulphate group to sialic acid is on residue O-8. 
Although a form of Neu5Gc8S has been identified, a sulphated form of Neu5Ac has as of yet not 
been isolated. 
 
There is a close relationship between the B. thetaiotamicron and the gut health. It has been suggested 
that the relationship is one of mutualism rather than B. thetaiotamicron acting as a commensal as 
both the host and the bacteria benefit from the relationship. The high predominance of sialic acid 
within the gut makes it a prime growth substrate for the bacteria in the gut. The importance of sialic 
acid metabolism stems from the important roles played by sialic acid within the human including 
immune regulation and cell-cell interactions. A high proportion of the sialic acids within the gut are 
found as di-acetylated forms, the deacetylation of which has been associated with the progression of 
cancer. This study highlights the prevalence of sialate-O-acetylesterase across the Bacteroides species. 
In particular a series of putative acetylesterases in the most prevalent gut bacteria B. thetaiotamicron 
have been established to have acetylesterase activity. 
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